Transform raw SEC Edgar data into actionable insights. See what company insiders are really doing, before the market catches on.
Start by searching a company name or ticker symbol above to unlock detailed visualizations.
Our interactive stock charts map out price history alongside every buy and sell transaction by company insiders, complete with volume data. Instantly spot trends and significant activities sourced directly from SEC filings.
Go beyond simple trades. Our transaction volume bar charts clearly identify the largest buyers and sellers within a company, revealing who holds the most conviction and potential influence derived from SEC data.
Track the largest shareholders and monitor how their positions evolve over your chosen timeframe. Understand ownership concentration and significant changes in holdings with our detailed breakdown, all from SEC filings.
Navigate the sea of insider trading data with ease. Our powerful and intuitive filters let you zero in on specific transaction types, insiders, date ranges, dollar amounts, and more, giving you exactly the information you need from SEC reports.
At Penguin Stock, we're committed to providing the most accurate and timely insider trading information, sourced directly from official SEC Edgar filings. Our platform is designed for an unparalleled user experience, empowering you to make informed decisions. Discover the transparency and power of raw financial data, beautifully visualized to give you an edge in analyzing stock trends and shareholder activity.
| Name | Last Transaction | Δ Change | Shares Owned | Value Owned | % of Company Owned |
|---|---|---|---|---|---|
|
Alex Gorsky
|
--
--
|
0.00%
|
--
|
0.03%
|
|
|
Joaquin Duato
CEO and Chairman of the Board
|
--
--
|
-12.66%
|
--
|
0.01%
|
|
|
Paulus Stoffels
Vice Chair, Exec Committee
|
--
--
|
0.00%
|
--
|
0.01%
|
|
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
--
--
|
9.23%
|
--
|
0.01%
|
|
|
Dominic J Caruso
Exec VP, Finance; CFO
|
--
--
|
0.00%
|
--
|
0.01%
|
|
|
Michael H Ullmann
Exec VP, General Counsel
|
--
--
|
0.00%
|
--
|
0.01%
|
|
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
--
--
|
21.22%
|
--
|
0.00%
|
|
|
Peter Fasolo
Exec VP, Chief HR Officer
|
--
--
|
0.00%
|
--
|
0.00%
|
|
|
Sandra E Peterson
Exec VP, Group WW Chairman
|
--
--
|
0.00%
|
--
|
0.00%
|
|
|
Joseph J Wolk
Exec VP, CFO
|
--
--
|
0.00%
|
--
|
0.00%
|
|
|
Thibaut Mongon
Exec VP, WW Chair, Cons Health
|
--
--
|
0.00%
|
--
|
0.00%
|
|
|
Michael E Sneed
EVP, Global Corp Aff & CCO
|
--
--
|
0.00%
|
--
|
0.00%
|
|
|
Ashley Mcevoy
EVP, WW Chair, MedTech
|
--
--
|
0.00%
|
--
|
0.00%
|
|
|
Gary J Pruden
Exec VP, WW Chair, Med Devices
|
--
--
|
0.00%
|
--
|
0.00%
|
|
|
Mathai Mammen
EVP, Pharm, R&D
|
--
--
|
0.00%
|
--
|
0.00%
|
|
|
William Hait
EVP, Chief EI and Med Officer
|
--
--
|
0.00%
|
--
|
0.00%
|
|
|
Charles Prince
|
--
--
|
0.00%
|
--
|
0.00%
|
|
|
Jorge S. Mesquita
Exec VP, WW Chair, Consumer
|
--
--
|
0.00%
|
--
|
0.00%
|
|
|
James D. Swanson
EVP, CIO
|
--
--
|
36.34%
|
--
|
0.00%
|
|
|
Timothy Schmid
EVP, WW Chair, MedTech
|
--
--
|
50.67%
|
--
|
0.00%
|
|
|
William D Perez
|
--
--
|
0.00%
|
--
|
0.00%
|
|
|
Robert J Decker
VP Corporate Controller
|
--
--
|
12.77%
|
--
|
0.00%
|
|
|
Elizabeth Forminard
EVP, Chief Legal Officer
|
--
--
|
116.18%
|
--
|
0.00%
|
|
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
--
--
|
-2.50%
|
--
|
0.00%
|
|
|
Kristen Mulholland
EVP, Chief HR Officer
|
--
--
|
40.45%
|
--
|
0.00%
|
|
|
Ronald A Kapusta
Controller, CAO
|
--
--
|
0.00%
|
--
|
0.00%
|
|
|
John C Reed
EVP, Innovative Medicine, R&D
|
--
--
|
-31.42%
|
--
|
0.00%
|
|
|
Anne M Mulcahy
|
--
--
|
0.00%
|
--
|
0.00%
|
|
|
Hubert Joly
|
--
--
|
0.00%
|
--
|
0.00%
|
|
|
Marillyn A Hewson
|
--
--
|
0.00%
|
--
|
0.00%
|
|
|
John G Morikis
|
--
--
|
--
|
--
|
0.00%
|
|
|
Mark A Weinberger
|
--
--
|
0.00%
|
--
|
0.00%
|
|
|
Eugene A. Woods
|
--
--
|
0.00%
|
--
|
0.00%
|
|
|
Paula A Johnson
|
--
--
|
--
|
--
|
0.00%
|
|
|
Total
|
2,890,615 | -- |
0.12%
|
| DATE | INSIDER & POSITION | TRANSACTION | % CHANGE | SHARES | PRICE | AMOUNT | NOTES |
|---|---|---|---|---|---|---|---|
|
02/20/26
Filed: 02/23/26
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Sell
Open Market Sell
|
-5.20% | 1,322 | $245.66 | $324,763 | |
|
02/13/26
Filed: *02/18/26
|
James D. Swanson
EVP, CIO
|
Buy
Option Exercised
|
+2.32% | 447 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
James D. Swanson
EVP, CIO
|
Sell
For Tax Liability
|
-0.75% | 143 | $244.55 | $34,971 | |
|
02/13/26
Filed: *02/18/26
|
James D. Swanson
EVP, CIO
|
Buy
Option Exercised
|
+32.95% | 9,412 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
James D. Swanson
EVP, CIO
|
Sell
For Tax Liability
|
-14.18% | 3,547 | $244.55 | $867,419 | |
|
02/13/26
Filed: *02/18/26
|
James D. Swanson
EVP, CIO
|
Buy
Option Exercised
|
+43.63% | 19,368 | $165.89 | $3,212,958 | |
|
02/13/26
Filed: *02/18/26
|
James D. Swanson
EVP, CIO
|
Sell
Open Market Sell
|
-77.41% | 19,368 | $243.76 | $4,721,144 | |
|
02/13/26
Filed: *02/18/26
|
James D. Swanson
EVP, CIO
|
Buy
Option Exercised
|
+47.00% | 22,191 | $162.75 | $3,611,585 | |
|
02/13/26
Filed: *02/18/26
|
James D. Swanson
EVP, CIO
|
Sell
Open Market Sell
|
-88.69% | 22,191 | $243.71 | $5,408,169 | |
|
02/13/26
Filed: *02/18/26
|
James D. Swanson
EVP, CIO
|
Buy
Option Exercised
|
+1.93% | 492 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
James D. Swanson
EVP, CIO
|
Sell
For Tax Liability
|
-0.85% | 214 | $243.45 | $52,098 | |
|
02/13/26
Filed: *02/18/26
|
James D. Swanson
EVP, CIO
|
Buy
Option Exercised
|
+2.73% | 709 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
James D. Swanson
EVP, CIO
|
Sell
For Tax Liability
|
-1.20% | 309 | $243.45 | $75,226 | |
|
02/13/26
Filed: *02/18/26
|
James D. Swanson
EVP, CIO
|
Buy
Option Exercised
|
+44.40% | 20,521 | $164.62 | $3,378,167 | |
|
02/13/26
Filed: *02/18/26
|
James D. Swanson
EVP, CIO
|
Sell
Open Market Sell
|
-79.85% | 20,521 | $242.70 | $4,980,447 | |
|
02/13/26
Filed: *02/18/26
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Buy
Option Exercised
|
+0.61% | 651 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Sell
For Tax Liability
|
-0.20% | 217 | $244.55 | $53,067 | |
|
02/13/26
Filed: *02/18/26
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Buy
Option Exercised
|
+11.41% | 13,706 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Sell
For Tax Liability
|
-5.64% | 6,414 | $244.55 | $1,568,544 | |
|
02/13/26
Filed: *02/18/26
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Buy
Option Exercised
|
+0.53% | 606 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Sell
For Tax Liability
|
-0.27% | 310 | $243.45 | $75,470 | |
|
02/13/26
Filed: *02/18/26
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Buy
Option Exercised
|
+0.55% | 635 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Sell
For Tax Liability
|
-0.28% | 325 | $243.45 | $79,121 | |
|
02/13/26
Filed: *02/18/26
|
Kristen Mulholland
EVP, Chief HR Officer
|
Buy
Option Exercised
|
+2.44% | 410 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Kristen Mulholland
EVP, Chief HR Officer
|
Sell
For Tax Liability
|
-0.81% | 135 | $244.55 | $33,014 | |
|
02/13/26
Filed: *02/18/26
|
Kristen Mulholland
EVP, Chief HR Officer
|
Buy
Option Exercised
|
+17.76% | 3,602 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Kristen Mulholland
EVP, Chief HR Officer
|
Sell
For Tax Liability
|
-5.33% | 1,027 | $244.55 | $251,153 | |
|
02/13/26
Filed: *02/18/26
|
Kristen Mulholland
EVP, Chief HR Officer
|
Buy
Option Exercised
|
+2.13% | 419 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Kristen Mulholland
EVP, Chief HR Officer
|
Sell
For Tax Liability
|
-0.88% | 172 | $243.45 | $41,873 | |
|
02/13/26
Filed: *02/18/26
|
Kristen Mulholland
EVP, Chief HR Officer
|
Buy
Option Exercised
|
+2.86% | 575 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Kristen Mulholland
EVP, Chief HR Officer
|
Sell
For Tax Liability
|
-1.27% | 251 | $243.45 | $61,106 | |
|
02/13/26
Filed: *02/18/26
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+72.80% | 37,463 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Joseph J Wolk
Exec VP, CFO
|
Sell
For Tax Liability
|
-44.90% | 15,948 | $244.55 | $3,900,083 | |
|
02/13/26
Filed: *02/18/26
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+4.77% | 1,779 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Joseph J Wolk
Exec VP, CFO
|
Sell
For Tax Liability
|
-1.38% | 507 | $244.55 | $123,987 | |
|
02/13/26
Filed: *02/18/26
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+5.09% | 1,971 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Joseph J Wolk
Exec VP, CFO
|
Sell
For Tax Liability
|
-2.26% | 858 | $243.45 | $208,880 | |
|
02/13/26
Filed: *02/18/26
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+4.72% | 1,878 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Joseph J Wolk
Exec VP, CFO
|
Sell
For Tax Liability
|
-2.10% | 817 | $243.45 | $198,899 | |
|
02/13/26
Filed: *02/18/26
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+33.06% | 19,241 | $115.67 | $2,225,606 | |
|
02/13/26
Filed: *02/18/26
|
Joseph J Wolk
Exec VP, CFO
|
Sell
Open Market Sell
|
-49.39% | 19,241 | $242.99 | $4,675,371 | |
|
02/13/26
Filed: *02/18/26
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+23.65% | 12,066 | $129.51 | $1,562,668 | |
|
02/13/26
Filed: *02/18/26
|
Joseph J Wolk
Exec VP, CFO
|
Sell
Open Market Sell
|
-30.97% | 12,066 | $242.87 | $2,930,469 | |
|
02/13/26
Filed: *02/18/26
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+46.15% | 33,386 | $131.94 | $4,404,949 | |
|
02/13/26
Filed: *02/18/26
|
Joseph J Wolk
Exec VP, CFO
|
Sell
Open Market Sell
|
-85.69% | 33,386 | $242.75 | $8,104,452 | |
|
02/13/26
Filed: *02/18/26
|
Joseph J Wolk
Exec VP, CFO
|
Sell
Open Market Sell
|
-178.29% | 24,961 | $242.68 | $6,057,535 | |
|
02/13/26
Filed: *02/18/26
|
Robert J Decker
VP Corporate Controller
|
Buy
Option Exercised
|
+1.46% | 312 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Robert J Decker
VP Corporate Controller
|
Sell
For Tax Liability
|
-0.49% | 104 | $244.55 | $25,433 | |
|
02/13/26
Filed: *02/18/26
|
Robert J Decker
VP Corporate Controller
|
Buy
Option Exercised
|
+11.44% | 2,741 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Robert J Decker
VP Corporate Controller
|
Sell
For Tax Liability
|
-3.29% | 762 | $244.55 | $186,347 | |
|
02/13/26
Filed: *02/18/26
|
Robert J Decker
VP Corporate Controller
|
Buy
Option Exercised
|
+1.44% | 339 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Robert J Decker
VP Corporate Controller
|
Sell
For Tax Liability
|
-0.40% | 94 | $243.45 | $22,884 | |
|
02/13/26
Filed: *02/18/26
|
Robert J Decker
VP Corporate Controller
|
Buy
Option Exercised
|
+1.45% | 344 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Robert J Decker
VP Corporate Controller
|
Sell
For Tax Liability
|
-0.40% | 95 | $243.45 | $23,128 | |
|
02/15/26
Filed: *02/18/26
|
John C Reed
EVP, Innovative Medicine, R&D
|
Buy
Option Exercised
|
+11.24% | 1,349 | N/A | $0 | |
|
02/15/26
Filed: *02/18/26
|
John C Reed
EVP, Innovative Medicine, R&D
|
Sell
For Tax Liability
|
-3.31% | 385 | $243.45 | $93,728 | |
|
02/15/26
Filed: *02/18/26
|
John C Reed
EVP, Innovative Medicine, R&D
|
Buy
Option Exercised
|
+13.71% | 1,847 | N/A | $0 | |
|
02/15/26
Filed: *02/18/26
|
John C Reed
EVP, Innovative Medicine, R&D
|
Sell
For Tax Liability
|
-4.08% | 528 | $243.45 | $128,542 | |
|
02/15/26
Filed: *02/18/26
|
John C Reed
EVP, Innovative Medicine, R&D
|
Buy
Option Exercised
|
+62.67% | 21,721 | $157.92 | $3,430,180 | |
|
02/15/26
Filed: *02/18/26
|
John C Reed
EVP, Innovative Medicine, R&D
|
Sell
Open Market Sell
|
-167.85% | 21,721 | $243.00 | $5,278,203 | |
|
02/15/26
Filed: *02/18/26
|
John C Reed
EVP, Innovative Medicine, R&D
|
Buy
Option Exercised
|
+69.81% | 29,927 | $156.15 | $4,673,101 | |
|
02/15/26
Filed: *02/18/26
|
John C Reed
EVP, Innovative Medicine, R&D
|
Sell
Open Market Sell
|
-231.26% | 29,927 | $243.00 | $7,272,261 | |
|
02/15/26
Filed: *02/18/26
|
John C Reed
EVP, Innovative Medicine, R&D
|
Sell
Open Market Sell
|
-21.42% | 2,283 | $243.00 | $554,769 | |
|
02/13/26
Filed: *02/18/26
|
Elizabeth Forminard
EVP, Chief Legal Officer
|
Buy
Option Exercised
|
+4.02% | 651 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Elizabeth Forminard
EVP, Chief Legal Officer
|
Sell
For Tax Liability
|
-1.98% | 314 | $244.55 | $76,789 | |
|
02/13/26
Filed: *02/18/26
|
Elizabeth Forminard
EVP, Chief Legal Officer
|
Buy
Option Exercised
|
+46.32% | 13,706 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Elizabeth Forminard
EVP, Chief Legal Officer
|
Sell
For Tax Liability
|
-31.05% | 7,011 | $244.55 | $1,714,540 | |
|
02/13/26
Filed: *02/18/26
|
Elizabeth Forminard
EVP, Chief Legal Officer
|
Buy
Option Exercised
|
+4.08% | 961 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Elizabeth Forminard
EVP, Chief Legal Officer
|
Sell
For Tax Liability
|
-2.13% | 492 | $243.45 | $119,777 | |
|
02/13/26
Filed: *02/18/26
|
Elizabeth Forminard
EVP, Chief Legal Officer
|
Buy
Option Exercised
|
+4.41% | 1,063 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Elizabeth Forminard
EVP, Chief Legal Officer
|
Sell
For Tax Liability
|
-2.31% | 544 | $243.45 | $132,437 | |
|
02/13/26
Filed: *02/18/26
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Buy
Option Exercised
|
+0.73% | 1,302 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Sell
For Tax Liability
|
-0.23% | 409 | $244.55 | $100,021 | |
|
02/13/26
Filed: *02/18/26
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Buy
Option Exercised
|
+13.29% | 27,412 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Sell
For Tax Liability
|
-7.03% | 13,547 | $244.55 | $3,312,919 | |
|
02/13/26
Filed: *02/18/26
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Buy
Option Exercised
|
+0.82% | 1,594 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Sell
For Tax Liability
|
-0.42% | 816 | $243.45 | $198,655 | |
|
02/13/26
Filed: *02/18/26
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Buy
Option Exercised
|
+0.95% | 1,847 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Sell
For Tax Liability
|
-0.49% | 945 | $243.45 | $230,060 | |
|
02/13/26
Filed: *02/18/26
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Buy
Option Exercised
|
+2.21% | 499 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Sell
For Tax Liability
|
-0.04% | 8 | $244.55 | $1,956 | |
|
02/13/26
Filed: *02/18/26
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Buy
Option Exercised
|
+16.22% | 4,378 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Sell
For Tax Liability
|
-7.21% | 1,816 | $244.55 | $444,103 | |
|
02/13/26
Filed: *02/18/26
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Buy
Option Exercised
|
+3.92% | 1,028 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Sell
For Tax Liability
|
-0.06% | 15 | $243.45 | $3,652 | |
|
02/13/26
Filed: *02/18/26
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Buy
Option Exercised
|
+3.77% | 1,026 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Sell
For Tax Liability
|
-1.67% | 448 | $243.45 | $109,066 | |
|
02/13/26
Filed: *02/18/26
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Buy
Option Exercised
|
+33.73% | 13,625 | $115.67 | $1,576,004 | |
|
02/13/26
Filed: *02/18/26
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Sell
Open Market Sell
|
-50.90% | 13,625 | $244.20 | $3,327,225 | |
|
02/13/26
Filed: *02/18/26
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Buy
Option Exercised
|
+25.16% | 8,998 | $129.51 | $1,165,331 | |
|
02/13/26
Filed: *02/18/26
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Sell
Open Market Sell
|
-33.61% | 8,998 | $244.53 | $2,200,281 | |
|
02/13/26
Filed: *02/18/26
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Option Exercised
|
+1.24% | 3,469 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
For Tax Liability
|
-0.36% | 989 | $244.55 | $241,860 | |
|
02/13/26
Filed: *02/18/26
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Option Exercised
|
+20.78% | 73,054 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
For Tax Liability
|
-9.91% | 31,679 | $244.55 | $7,747,099 | |
|
02/13/26
Filed: *02/18/26
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Option Exercised
|
+1.14% | 3,682 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
For Tax Liability
|
-0.50% | 1,602 | $243.45 | $390,007 | |
|
02/13/26
Filed: *02/18/26
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Option Exercised
|
+1.38% | 4,505 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
For Tax Liability
|
-0.60% | 1,960 | $243.45 | $477,162 | |
|
02/13/26
Filed: *02/18/26
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Buy
Option Exercised
|
+1.70% | 408 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Sell
For Tax Liability
|
-0.60% | 144 | $244.55 | $35,215 | |
|
02/13/26
Filed: *02/18/26
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Buy
Option Exercised
|
+26.48% | 8,594 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Sell
For Tax Liability
|
-13.06% | 3,748 | $244.55 | $916,573 | |
|
02/13/26
Filed: *02/18/26
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Buy
Option Exercised
|
+1.69% | 492 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Sell
For Tax Liability
|
-0.87% | 252 | $243.45 | $61,349 | |
|
02/13/26
Filed: *02/18/26
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Buy
Option Exercised
|
+1.78% | 526 | N/A | $0 | |
|
02/13/26
Filed: *02/18/26
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Sell
For Tax Liability
|
-0.92% | 270 | $243.45 | $65,732 | |
|
02/13/26
Filed: *02/18/26
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Sell
Open Market Sell
|
-26.94% | 6,197 | $243.39 | $1,508,288 | |
|
02/06/26
Filed: *02/10/26
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Buy
Option Exercised
|
+47.97% | 15,571 | $101.87 | $1,586,218 | |
|
02/06/26
Filed: *02/10/26
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Sell
For Tax Liability
|
-46.71% | 10,335 | $239.99 | $2,480,297 | |
|
02/06/26
Filed: *02/09/26
|
Kristen Mulholland
EVP, Chief HR Officer
|
Buy
Option Exercised
|
+28.49% | 5,625 | $101.87 | $573,019 | |
|
02/06/26
Filed: *02/09/26
|
Kristen Mulholland
EVP, Chief HR Officer
|
Sell
For Tax Liability
|
-20.32% | 3,335 | $239.99 | $800,367 | |
|
02/06/26
Filed: *02/09/26
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Buy
Option Exercised
|
+29.23% | 38,945 | $101.87 | $3,967,327 | |
|
02/06/26
Filed: *02/09/26
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Sell
For Tax Liability
|
-25.74% | 27,270 | $239.99 | $6,544,527 | |
|
02/05/26
Filed: *02/06/26
|
Elizabeth Forminard
EVP, Chief Legal Officer
|
Buy
Option Exercised
|
+40.97% | 8,921 | $129.51 | $1,155,359 | |
|
02/05/26
Filed: *02/06/26
|
Elizabeth Forminard
EVP, Chief Legal Officer
|
Sell
For Tax Liability
|
-40.04% | 6,226 | $237.90 | $1,481,165 | |
|
08/23/23
Filed: 01/28/26
|
Paula A Johnson
|
Sell
Disposition to the issuer
|
-12.36% | 11 | N/A | $0 | |
|
01/26/26
Filed: *01/28/26
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
Open Market Sell
|
-64.32% | 51,218 | $220.99 | $11,318,461 | |
|
01/26/26
Filed: *01/28/26
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
Open Market Sell
|
-158.12% | 48,782 | $221.48 | $10,804,432 | |
|
11/26/25
Filed: 12/01/25
|
John G Morikis
|
Buy
Open Market Buy
|
+67.62% | 1,250 | $206.15 | $257,688 | - |
|
10/17/25
Filed: *10/20/25
|
John C Reed
EVP, Innovative Medicine, R&D
|
Buy
Option Exercised
|
+67.08% | 21,721 | $157.92 | $3,430,180 | |
|
10/17/25
Filed: *10/20/25
|
John C Reed
EVP, Innovative Medicine, R&D
|
Sell
Open Market Sell
|
-203.80% | 21,721 | $192.71 | $4,185,793 | |
|
09/04/25
Filed: *09/05/25
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Buy
Option Exercised
|
+24.08% | 56,471 | $101.87 | $5,752,701 | |
|
09/04/25
Filed: *09/05/25
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Sell
Open Market Sell
|
-31.72% | 56,471 | $177.81 | $10,040,883 | |
|
08/29/25
Filed: *09/03/25
|
Elizabeth Forminard
Executive VP, General Counsel
|
Buy
Option Exercised
|
+51.38% | 11,521 | $115.67 | $1,332,634 | |
|
08/29/25
Filed: *09/03/25
|
Elizabeth Forminard
Executive VP, General Counsel
|
Sell
For Tax Liability
|
-74.46% | 9,570 | $177.20 | $1,695,804 | |
|
08/22/25
Filed: *08/25/25
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Option Exercised
|
+31.32% | 125,824 | $101.87 | $12,817,691 | |
|
08/22/25
Filed: *08/25/25
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
Open Market Sell
|
-45.59% | 125,824 | $179.21 | $22,548,655 | |
|
08/15/25
Filed: *08/18/25
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+54.57% | 16,820 | $101.87 | $1,713,453 | |
|
08/15/25
Filed: *08/18/25
|
Joseph J Wolk
Exec VP, CFO
|
Sell
Open Market Sell
|
-120.14% | 16,820 | $176.91 | $2,975,571 | |
|
07/17/25
Filed: 07/18/25
|
John C Reed
EVP, Innovative Medicine, R&D
|
Sell
Open Market Sell
|
-179.56% | 19,137 | $163.55 | $3,129,830 | |
|
05/01/25
Filed: *05/05/25
|
John C Reed
EVP, Innovative Medicine, R&D
|
Buy
Option Exercised
|
+61.90% | 25,255 | N/A | $0 | |
|
05/01/25
Filed: *05/05/25
|
John C Reed
EVP, Innovative Medicine, R&D
|
Sell
For Tax Liability
|
-36.93% | 11,002 | $156.31 | $1,719,723 | |
|
03/18/25
Filed: *03/19/25
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
Bona Fide Gift
|
-47.42% | 130,852 | N/A | $0 | |
|
03/18/25
Filed: *03/19/25
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Bona Fide Gift
|
+100.00% | 130,852 | N/A | $0 | |
|
12/31/24
Filed: 02/28/25
|
Eugene A. Woods
|
Buy
Open Market Buy
|
+40.00% | 100 | $145.53 | $14,553 | |
|
02/25/25
Filed: *02/26/25
|
Robert J Decker
VP Corporate Controller
|
Buy
Option Exercised
|
+25.00% | 6,999 | $101.87 | $712,988 | |
|
02/25/25
Filed: *02/26/25
|
Robert J Decker
VP Corporate Controller
|
Sell
Open Market Sell
|
-33.33% | 6,999 | $165.88 | $1,160,994 | |
|
02/14/25
Filed: *02/18/25
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Buy
Option Exercised
|
+15.67% | 2,806 | N/A | $0 | |
|
02/14/25
Filed: *02/18/25
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Sell
For Tax Liability
|
-6.01% | 1,015 | $156.71 | $159,061 | |
|
02/13/25
Filed: *02/18/25
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Buy
Option Exercised
|
+3.69% | 499 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Sell
For Tax Liability
|
-1.45% | 193 | $155.26 | $29,965 | |
|
02/13/25
Filed: *02/18/25
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Buy
Option Exercised
|
+11.68% | 1,765 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Sell
For Tax Liability
|
-4.42% | 639 | $156.71 | $100,138 | |
|
02/13/25
Filed: *02/18/25
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Buy
Option Exercised
|
+6.64% | 1,029 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Sell
Open Market Sell
|
-2.67% | 403 | $156.15 | $62,928 | |
|
02/13/25
Filed: *02/18/25
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Buy
Option Exercised
|
+0.73% | 651 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Sell
For Tax Liability
|
-0.25% | 223 | $155.26 | $34,623 | |
|
02/13/25
Filed: *02/18/25
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Buy
Option Exercised
|
+1.68% | 1,530 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Sell
For Tax Liability
|
-0.53% | 480 | $156.71 | $75,221 | |
|
02/13/25
Filed: *02/18/25
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Buy
Option Exercised
|
+0.67% | 607 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Sell
For Tax Liability
|
-0.22% | 200 | $156.15 | $31,230 | |
|
02/13/25
Filed: *02/18/25
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Buy
Option Exercised
|
+6.04% | 5,837 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Sell
For Tax Liability
|
-2.54% | 2,393 | $156.71 | $375,007 | |
|
02/13/25
Filed: *02/18/25
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+100.00% | 1,779 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Joseph J Wolk
Exec VP, CFO
|
Sell
For Tax Liability
|
-39.86% | 507 | $155.26 | $78,717 | |
|
02/13/25
Filed: *02/18/25
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+75.94% | 4,014 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Joseph J Wolk
Exec VP, CFO
|
Sell
For Tax Liability
|
-27.62% | 1,144 | $156.71 | $179,276 | |
|
02/13/25
Filed: *02/18/25
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+32.24% | 1,971 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Joseph J Wolk
Exec VP, CFO
|
Sell
For Tax Liability
|
-14.37% | 768 | $156.15 | $119,923 | |
|
02/13/25
Filed: *02/18/25
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+74.13% | 15,316 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Joseph J Wolk
Exec VP, CFO
|
Sell
For Tax Liability
|
-47.58% | 6,661 | $156.71 | $1,043,845 | |
|
02/15/25
Filed: *02/18/25
|
John C Reed
EVP, Innovative Medicine, R&D
|
Buy
Option Exercised
|
+8.48% | 1,350 | N/A | $0 | |
|
02/15/25
Filed: *02/18/25
|
John C Reed
EVP, Innovative Medicine, R&D
|
Sell
For Tax Liability
|
-2.48% | 385 | $156.15 | $60,118 | |
|
02/13/25
Filed: *02/18/25
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Buy
Option Exercised
|
+0.78% | 1,302 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Sell
For Tax Liability
|
-0.25% | 410 | $155.26 | $63,657 | |
|
02/13/25
Filed: *02/18/25
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Buy
Option Exercised
|
+2.37% | 4,053 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Sell
For Tax Liability
|
-0.80% | 1,348 | $156.71 | $211,245 | |
|
02/13/25
Filed: *02/18/25
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Buy
Option Exercised
|
+0.93% | 1,594 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Sell
For Tax Liability
|
-0.38% | 651 | $156.15 | $101,654 | |
|
02/13/25
Filed: *02/18/25
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Buy
Option Exercised
|
+8.32% | 15,465 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Sell
For Tax Liability
|
-4.44% | 7,911 | $156.71 | $1,239,733 | |
|
02/13/25
Filed: *02/18/25
|
James D. Swanson
EVP, CIO
|
Buy
Option Exercised
|
+2.98% | 447 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
James D. Swanson
EVP, CIO
|
Sell
For Tax Liability
|
-1.02% | 152 | $155.26 | $23,600 | |
|
02/13/25
Filed: *02/18/25
|
James D. Swanson
EVP, CIO
|
Buy
Option Exercised
|
+11.65% | 1,961 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
James D. Swanson
EVP, CIO
|
Sell
For Tax Liability
|
-3.43% | 558 | $156.71 | $87,444 | |
|
02/13/25
Filed: *02/18/25
|
James D. Swanson
EVP, CIO
|
Buy
Option Exercised
|
+2.94% | 492 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
James D. Swanson
EVP, CIO
|
Sell
For Tax Liability
|
-0.85% | 141 | $156.15 | $22,017 | |
|
02/13/25
Filed: *02/18/25
|
James D. Swanson
EVP, CIO
|
Buy
Option Exercised
|
+15.80% | 3,118 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
James D. Swanson
EVP, CIO
|
Sell
For Tax Liability
|
-4.72% | 889 | $156.71 | $139,315 | |
|
02/13/25
Filed: *02/18/25
|
Kristen Mulholland
EVP, Chief HR Officer
|
Buy
Option Exercised
|
+3.40% | 411 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Kristen Mulholland
EVP, Chief HR Officer
|
Sell
For Tax Liability
|
-1.18% | 141 | $155.26 | $21,892 | |
|
02/13/25
Filed: *02/18/25
|
Kristen Mulholland
EVP, Chief HR Officer
|
Buy
Option Exercised
|
+7.77% | 1,007 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Kristen Mulholland
EVP, Chief HR Officer
|
Sell
For Tax Liability
|
-2.29% | 290 | $156.71 | $45,446 | |
|
02/13/25
Filed: *02/18/25
|
Kristen Mulholland
EVP, Chief HR Officer
|
Buy
Option Exercised
|
+3.20% | 419 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Kristen Mulholland
EVP, Chief HR Officer
|
Sell
For Tax Liability
|
-0.92% | 120 | $156.15 | $18,738 | |
|
02/13/25
Filed: *02/18/25
|
Kristen Mulholland
EVP, Chief HR Officer
|
Buy
Option Exercised
|
+10.98% | 1,601 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Kristen Mulholland
EVP, Chief HR Officer
|
Sell
For Tax Liability
|
-3.24% | 457 | $156.71 | $71,616 | |
|
02/13/25
Filed: *02/18/25
|
Elizabeth Forminard
Executive VP, General Counsel
|
Buy
Option Exercised
|
+7.24% | 651 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Elizabeth Forminard
Executive VP, General Counsel
|
Sell
For Tax Liability
|
-2.45% | 215 | $155.26 | $33,381 | |
|
02/13/25
Filed: *02/18/25
|
Elizabeth Forminard
Executive VP, General Counsel
|
Buy
Option Exercised
|
+8.84% | 851 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Elizabeth Forminard
Executive VP, General Counsel
|
Sell
For Tax Liability
|
-2.85% | 267 | $156.71 | $41,842 | |
|
02/13/25
Filed: *02/18/25
|
Elizabeth Forminard
Executive VP, General Counsel
|
Buy
Option Exercised
|
+9.31% | 961 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Elizabeth Forminard
Executive VP, General Counsel
|
Sell
For Tax Liability
|
-3.07% | 307 | $156.15 | $47,938 | |
|
02/13/25
Filed: *02/18/25
|
Elizabeth Forminard
Executive VP, General Counsel
|
Buy
Option Exercised
|
+11.90% | 1,352 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Elizabeth Forminard
Executive VP, General Counsel
|
Sell
For Tax Liability
|
-4.26% | 464 | $156.71 | $72,713 | |
|
02/13/25
Filed: *02/18/25
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Option Exercised
|
+0.88% | 3,470 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
For Tax Liability
|
-0.39% | 1,510 | $155.26 | $234,443 | |
|
02/13/25
Filed: *02/18/25
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Option Exercised
|
+1.28% | 5,053 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
For Tax Liability
|
-0.56% | 2,198 | $156.71 | $344,449 | |
|
02/13/25
Filed: *02/18/25
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Option Exercised
|
+0.93% | 3,682 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
For Tax Liability
|
-0.40% | 1,602 | $156.15 | $250,152 | |
|
02/13/25
Filed: *02/18/25
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Option Exercised
|
+4.64% | 19,282 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
For Tax Liability
|
-2.06% | 8,386 | $156.71 | $1,314,170 | |
|
02/13/25
Filed: *02/18/25
|
Robert J Decker
VP Corporate Controller
|
Buy
Option Exercised
|
+1.62% | 312 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Robert J Decker
VP Corporate Controller
|
Sell
For Tax Liability
|
-0.54% | 104 | $155.26 | $16,147 | |
|
02/13/25
Filed: *02/18/25
|
Robert J Decker
VP Corporate Controller
|
Buy
Option Exercised
|
+4.24% | 850 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Robert J Decker
VP Corporate Controller
|
Sell
For Tax Liability
|
-1.28% | 254 | $156.71 | $39,804 | |
|
02/13/25
Filed: *02/18/25
|
Robert J Decker
VP Corporate Controller
|
Buy
Option Exercised
|
+1.69% | 339 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Robert J Decker
VP Corporate Controller
|
Sell
For Tax Liability
|
-0.47% | 94 | $156.15 | $14,678 | |
|
02/13/25
Filed: *02/18/25
|
Robert J Decker
VP Corporate Controller
|
Buy
Option Exercised
|
+6.32% | 1,351 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Robert J Decker
VP Corporate Controller
|
Sell
For Tax Liability
|
-1.77% | 372 | $156.71 | $58,296 | |
|
02/13/25
Filed: *02/18/25
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Buy
Option Exercised
|
+2.02% | 408 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Sell
For Tax Liability
|
-0.75% | 151 | $155.26 | $23,444 | |
|
02/13/25
Filed: *02/18/25
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Buy
Option Exercised
|
+8.35% | 1,830 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Sell
For Tax Liability
|
-2.69% | 574 | $156.71 | $89,952 | |
|
02/13/25
Filed: *02/18/25
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Buy
Option Exercised
|
+2.25% | 492 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Sell
For Tax Liability
|
-0.73% | 158 | $156.15 | $24,672 | |
|
02/13/25
Filed: *02/18/25
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Buy
Option Exercised
|
+11.83% | 2,910 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Sell
For Tax Liability
|
-4.23% | 997 | $156.71 | $156,240 | |
|
02/07/25
Filed: *02/11/25
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Option Exercised
|
+25.81% | 126,369 | $100.06 | $12,644,482 | |
|
02/07/25
Filed: *02/11/25
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
For Tax Liability
|
-25.87% | 100,643 | $153.12 | $15,410,456 | |
|
02/07/25
Filed: *02/11/25
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Buy
Option Exercised
|
+28.48% | 32,762 | $100.06 | $3,278,166 | |
|
02/07/25
Filed: *02/11/25
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Sell
For Tax Liability
|
-29.31% | 26,076 | $153.12 | $3,992,757 | |
|
02/07/25
Filed: *02/11/25
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Buy
Option Exercised
|
+27.42% | 58,504 | $100.06 | $5,853,910 | |
|
02/07/25
Filed: *02/11/25
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Sell
For Tax Liability
|
-28.59% | 47,436 | $153.12 | $7,263,400 | |
|
02/07/25
Filed: *02/11/25
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+100.00% | 13,015 | $100.06 | $1,302,281 | |
|
02/07/25
Filed: *02/11/25
|
Joseph J Wolk
Exec VP, CFO
|
Sell
Open Market Sell
|
-N/A | 13,015 | $153.89 | $2,002,878 | |
|
12/12/24
Filed: 12/12/24
|
Mark A Weinberger
|
Buy
Open Market Buy
|
+100.00% | 1,000 | $147.22 | $147,220 | - |
|
05/01/24
Filed: *10/31/24
|
John C Reed
EVP, Innovative Medicine, R&D
|
Buy
Option Exercised
|
+98.80% | 25,255 | N/A | $0 | |
|
05/01/24
Filed: *10/31/24
|
John C Reed
EVP, Innovative Medicine, R&D
|
Sell
For Tax Liability
|
-75.35% | 10,984 | $144.59 | $1,588,177 | |
|
05/01/24
Filed: *10/31/24
|
John C Reed
EVP, Innovative Medicine, R&D
|
Buy
Option Exercised
|
+98.80% | 25,255 | N/A | $0 | |
|
05/01/24
Filed: *10/31/24
|
John C Reed
EVP, Innovative Medicine, R&D
|
Sell
For Tax Liability
|
-75.35% | 10,984 | $144.59 | $1,588,177 | |
|
05/22/24
Filed: *10/21/24
|
Joseph J Wolk
Exec VP, CFO
|
Sell
Bona Fide Gift
|
-0.08% | 55 | N/A | $0 | |
|
05/22/24
Filed: *10/21/24
|
Joseph J Wolk
Exec VP, CFO
|
Sell
Bona Fide Gift
|
-N/A | 68,835 | N/A | $0 | |
|
05/22/24
Filed: *10/21/24
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Bona Fide Gift
|
+100.00% | 68,835 | N/A | $0 | |
|
08/30/24
Filed: *09/03/24
|
Robert J Decker
VP Corporate Controller
|
Buy
Option Exercised
|
+22.90% | 5,635 | $100.06 | $563,838 | |
|
08/30/24
Filed: *09/03/24
|
Robert J Decker
VP Corporate Controller
|
Sell
Open Market Sell
|
-29.70% | 5,635 | $165.06 | $930,113 | |
|
07/08/24
Filed: *07/09/24
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Buy
Option Exercised
|
+39.47% | 9,809 | N/A | $0 | |
|
07/08/24
Filed: *07/09/24
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Sell
For Tax Liability
|
-25.30% | 5,018 | $147.16 | $738,449 | |
|
03/13/24
Filed: 03/13/24
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Sell
Open Market Sell
|
-59.10% | 8,891 | $162.16 | $1,441,765 | |
|
02/13/24
Filed: *02/15/24
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Buy
Option Exercised
|
+0.79% | 651 | N/A | $0 | |
|
02/13/24
Filed: *02/15/24
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Sell
For Tax Liability
|
-0.40% | 333 | $157.85 | $52,564 | |
|
02/13/24
Filed: *02/15/24
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+2.56% | 1,780 | N/A | $0 | |
|
02/13/24
Filed: *02/15/24
|
Joseph J Wolk
Exec VP, CFO
|
Sell
For Tax Liability
|
-1.12% | 773 | $157.85 | $122,018 | |
|
02/13/24
Filed: *02/15/24
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Buy
Option Exercised
|
+0.84% | 1,302 | N/A | $0 | |
|
02/13/24
Filed: *02/15/24
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Sell
For Tax Liability
|
-0.43% | 666 | $157.85 | $105,128 | |
|
02/13/24
Filed: *02/15/24
|
James D. Swanson
EVP, CIO
|
Buy
Option Exercised
|
+3.03% | 447 | N/A | $0 | |
|
02/13/24
Filed: *02/15/24
|
James D. Swanson
EVP, CIO
|
Sell
For Tax Liability
|
-1.34% | 195 | $157.85 | $30,781 | |
|
02/13/24
Filed: *02/15/24
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Buy
Option Exercised
|
+3.75% | 499 | N/A | $0 | |
|
02/13/24
Filed: *02/15/24
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Sell
For Tax Liability
|
-1.92% | 250 | $157.85 | $39,462 | |
|
02/13/24
Filed: *02/15/24
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Buy
Option Exercised
|
+0.82% | 925 | N/A | $0 | |
|
02/13/24
Filed: *02/15/24
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
For Tax Liability
|
-0.42% | 474 | $157.85 | $74,821 | |
|
02/13/24
Filed: *02/15/24
|
William Hait
See Remarks
|
Buy
Option Exercised
|
+2.13% | 834 | N/A | $0 | |
|
02/13/24
Filed: *02/15/24
|
William Hait
See Remarks
|
Sell
For Tax Liability
|
-1.10% | 427 | $157.85 | $67,402 | |
|
02/13/24
Filed: *02/15/24
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Option Exercised
|
+0.95% | 3,470 | N/A | $0 | |
|
02/13/24
Filed: *02/15/24
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
For Tax Liability
|
-0.41% | 1,507 | $157.85 | $237,880 | |
|
02/13/24
Filed: *02/15/24
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Buy
Option Exercised
|
+1.69% | 408 | N/A | $0 | |
|
02/13/24
Filed: *02/15/24
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Sell
For Tax Liability
|
-0.87% | 209 | $157.85 | $32,991 | |
|
02/13/24
Filed: *02/15/24
|
Elizabeth Forminard
Executive VP, General Counsel
|
Buy
Option Exercised
|
+7.59% | 651 | N/A | $0 | |
|
02/13/24
Filed: *02/15/24
|
Elizabeth Forminard
Executive VP, General Counsel
|
Sell
For Tax Liability
|
-2.83% | 236 | $157.85 | $37,253 | |
|
02/13/24
Filed: *02/15/24
|
Robert J Decker
VP Corporate Controller
|
Buy
Option Exercised
|
+1.64% | 313 | N/A | $0 | |
|
02/13/24
Filed: *02/15/24
|
Robert J Decker
VP Corporate Controller
|
Sell
For Tax Liability
|
-0.45% | 86 | $157.85 | $13,575 | |
|
02/12/24
Filed: *02/14/24
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Buy
Option Exercised
|
+18.74% | 4,701 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Buy
Grant, Award
|
+3.05% | 790 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Sell
For Tax Liability
|
-9.00% | 2,136 | $157.40 | $336,206 | |
|
02/12/24
Filed: *02/14/24
|
William Hait
See Remarks
|
Buy
Option Exercised
|
+18.64% | 7,647 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
William Hait
See Remarks
|
Buy
Option Exercised
|
+3.04% | 1,285 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
William Hait
See Remarks
|
Sell
For Tax Liability
|
-10.66% | 4,076 | $157.40 | $641,562 | |
|
02/12/24
Filed: *02/14/24
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+29.50% | 22,119 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+4.72% | 3,716 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Joseph J Wolk
Exec VP, CFO
|
Sell
For Tax Liability
|
-15.93% | 10,816 | $157.40 | $1,702,438 | |
|
02/12/24
Filed: *02/14/24
|
Elizabeth Forminard
Executive VP, General Counsel
|
Buy
Option Exercised
|
+28.64% | 2,448 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Elizabeth Forminard
Executive VP, General Counsel
|
Buy
Option Exercised
|
+4.59% | 411 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Elizabeth Forminard
Executive VP, General Counsel
|
Sell
For Tax Liability
|
-13.05% | 1,034 | $157.40 | $162,752 | |
|
02/12/24
Filed: *02/14/24
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Buy
Option Exercised
|
+13.69% | 22,433 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Buy
Option Exercised
|
+2.25% | 3,769 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Sell
For Tax Liability
|
-8.69% | 13,403 | $157.40 | $2,109,632 | |
|
02/12/24
Filed: *02/14/24
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Buy
Option Exercised
|
+10.99% | 12,808 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Buy
Option Exercised
|
+1.81% | 2,152 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
For Tax Liability
|
-6.29% | 7,019 | $157.40 | $1,104,791 | |
|
02/12/24
Filed: *02/14/24
|
James D. Swanson
EVP, CIO
|
Buy
Option Exercised
|
+30.67% | 4,671 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
James D. Swanson
EVP, CIO
|
Buy
Option Exercised
|
+4.90% | 785 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
James D. Swanson
EVP, CIO
|
Sell
For Tax Liability
|
-11.84% | 1,695 | $157.40 | $266,793 | |
|
02/12/24
Filed: *02/14/24
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Option Exercised
|
+8.43% | 31,351 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Option Exercised
|
+1.40% | 5,267 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
For Tax Liability
|
-4.40% | 15,900 | $157.40 | $2,502,660 | |
|
02/12/24
Filed: *02/14/24
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Buy
Option Exercised
|
+33.06% | 4,911 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Buy
Option Exercised
|
+5.26% | 825 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Sell
For Tax Liability
|
-22.57% | 2,887 | $157.40 | $454,414 | |
|
02/12/24
Filed: *02/14/24
|
Robert J Decker
VP Corporate Controller
|
Buy
Option Exercised
|
+8.62% | 1,637 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Robert J Decker
VP Corporate Controller
|
Buy
Option Exercised
|
+1.43% | 275 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Robert J Decker
VP Corporate Controller
|
Sell
For Tax Liability
|
-2.79% | 523 | $157.40 | $82,320 | |
|
02/12/24
Filed: *02/14/24
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Buy
Option Exercised
|
+13.59% | 11,826 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Buy
Option Exercised
|
+2.23% | 1,987 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Sell
For Tax Liability
|
-8.62% | 7,066 | $157.40 | $1,112,188 | |
|
02/09/24
Filed: *02/13/24
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Buy
Option Exercised
|
+34.76% | 35,638 | $90.44 | $3,223,101 | |
|
02/09/24
Filed: *02/13/24
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Sell
For Tax Liability
|
-36.35% | 27,333 | $156.76 | $4,284,721 | |
|
02/09/24
Filed: *02/13/24
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Option Exercised
|
+29.81% | 130,969 | $90.44 | $11,844,836 | |
|
02/09/24
Filed: *02/13/24
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
For Tax Liability
|
-28.97% | 98,662 | $156.76 | $15,466,255 | |
|
02/08/24
Filed: *02/12/24
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Buy
Option Exercised
|
+2.61% | 3,739 | N/A | $0 | |
|
02/08/24
Filed: *02/12/24
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Sell
For Tax Liability
|
-1.35% | 1,913 | $156.33 | $299,059 | |
|
02/08/24
Filed: *02/12/24
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Buy
Option Exercised
|
+29.58% | 59,397 | $90.44 | $5,371,865 | |
|
02/08/24
Filed: *02/12/24
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Sell
Open Market Sell
|
-42.00% | 59,397 | $156.27 | $9,281,969 | |
|
02/08/24
Filed: *02/12/24
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Option Exercised
|
+1.68% | 5,225 | N/A | $0 | |
|
02/08/24
Filed: *02/12/24
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
For Tax Liability
|
-0.74% | 2,269 | $156.33 | $354,713 | |
|
02/08/24
Filed: *02/12/24
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Buy
Option Exercised
|
+2.90% | 1,971 | N/A | $0 | |
|
02/08/24
Filed: *02/12/24
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Sell
For Tax Liability
|
-1.51% | 1,009 | $156.33 | $157,737 | |
|
02/08/24
Filed: *02/12/24
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+6.84% | 3,686 | N/A | $0 | |
|
02/08/24
Filed: *02/12/24
|
Joseph J Wolk
Exec VP, CFO
|
Sell
For Tax Liability
|
-1.98% | 1,047 | $156.33 | $163,678 | |
|
02/08/24
Filed: *02/12/24
|
Elizabeth Forminard
Executive VP, General Counsel
|
Buy
Option Exercised
|
+15.15% | 979 | N/A | $0 | |
|
02/08/24
Filed: *02/12/24
|
Elizabeth Forminard
Executive VP, General Counsel
|
Sell
For Tax Liability
|
-5.95% | 363 | $156.33 | $56,748 | |
|
02/08/24
Filed: *02/12/24
|
James D. Swanson
See Remarks
|
Buy
Option Exercised
|
+16.81% | 1,868 | N/A | $0 | |
|
02/08/24
Filed: *02/12/24
|
James D. Swanson
See Remarks
|
Sell
For Tax Liability
|
-5.25% | 554 | $156.33 | $86,607 | |
|
02/08/24
Filed: *02/12/24
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Buy
Option Exercised
|
+17.95% | 1,964 | N/A | $0 | |
|
02/08/24
Filed: *02/12/24
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Sell
For Tax Liability
|
-10.07% | 1,001 | $156.33 | $156,486 | |
|
02/08/24
Filed: *02/12/24
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Buy
Option Exercised
|
+2.04% | 2,135 | N/A | $0 | |
|
02/08/24
Filed: *02/12/24
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
For Tax Liability
|
-0.75% | 781 | $156.33 | $122,094 | |
|
02/08/24
Filed: *02/12/24
|
William Hait
See Remarks
|
Buy
Option Exercised
|
+8.87% | 3,059 | N/A | $0 | |
|
02/08/24
Filed: *02/12/24
|
William Hait
See Remarks
|
Sell
For Tax Liability
|
-3.33% | 1,113 | $156.33 | $173,995 | |
|
02/08/24
Filed: *02/12/24
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Buy
Option Exercised
|
+8.92% | 1,880 | N/A | $0 | |
|
02/08/24
Filed: *02/12/24
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Sell
For Tax Liability
|
-3.45% | 703 | $156.33 | $109,900 | |
|
02/08/24
Filed: *02/12/24
|
Robert J Decker
VP Corporate Controller
|
Buy
Option Exercised
|
+3.73% | 655 | N/A | $0 | |
|
02/08/24
Filed: *02/12/24
|
Robert J Decker
VP Corporate Controller
|
Sell
For Tax Liability
|
-1.24% | 215 | $156.33 | $33,611 | |
|
08/23/23
Filed: 08/25/23
|
William Hait
See Remarks
|
Sell
Disposition to the issuer
|
-0.80% | 696 | N/A | $0 | |
|
08/23/23
Filed: 08/25/23
|
Ashley Mcevoy
EVP, WW Chair, MedTech
|
Sell
Disposition to the issuer
|
-5.36% | 2,787 | N/A | $0 | |
|
08/23/23
Filed: 08/25/23
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Disposition to the issuer
|
-0.23% | 232 | N/A | $0 | |
|
08/23/23
Filed: 08/25/23
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
Disposition to the issuer
|
-3.61% | 11,035 | N/A | $0 | |
|
08/23/23
Filed: 08/25/23
|
Joseph J Wolk
Exec VP, CFO
|
Sell
Disposition to the issuer
|
-0.13% | 67 | N/A | $0 | |
|
07/25/23
Filed: 07/27/23
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-19.47% | 20,000 | $170.32 | $3,406,498 | |
|
07/26/23
Filed: *07/27/23
|
William Hait
See Remarks
|
Buy
Option Exercised
|
+14.35% | 14,698 | $90.44 | $1,329,287 | - |
|
07/26/23
Filed: *07/27/23
|
William Hait
See Remarks
|
Sell
Open Market Sell
|
-16.75% | 14,698 | $172.00 | $2,528,056 | - |
|
06/12/23
Filed: 06/14/23
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Sell
Open Market Sell
|
-18.91% | 12,465 | $160.00 | $1,994,400 | |
|
05/24/23
Filed: 05/25/23
|
Joseph J Wolk
Exec VP, CFO
|
Sell
Bona Fide Gift
|
-0.11% | 55 | N/A | $0 | |
|
03/06/23
Filed: 03/08/23
|
James D. Swanson
See Remarks
|
Sell
Open Market Sell
|
-11.52% | 1,061 | $154.66 | $164,199 | - |
|
02/13/23
Filed: *02/15/23
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Grant, Award
|
+35.09% | 20,693 | N/A | $0 | |
|
02/13/23
Filed: *02/15/23
|
Joseph J Wolk
Exec VP, CFO
|
Sell
For Tax Liability
|
-17.02% | 8,578 | $162.01 | $1,389,722 | |
|
02/13/23
Filed: *02/15/23
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Buy
Grant, Award
|
+13.01% | 10,839 | N/A | $0 | |
|
02/13/23
Filed: *02/15/23
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Sell
For Tax Liability
|
-6.24% | 4,891 | $162.01 | $792,391 | |
|
02/13/23
Filed: *02/15/23
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Buy
Grant, Award
|
+14.27% | 21,422 | N/A | $0 | |
|
02/13/23
Filed: *02/15/23
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Sell
For Tax Liability
|
-7.57% | 10,569 | $162.01 | $1,712,284 | |
|
02/13/23
Filed: *02/15/23
|
James D. Swanson
See Remarks
|
Buy
Grant, Award
|
+28.83% | 3,228 | N/A | $0 | |
|
02/13/23
Filed: *02/15/23
|
James D. Swanson
See Remarks
|
Sell
For Tax Liability
|
-8.93% | 918 | $162.01 | $148,725 | |
|
02/13/23
Filed: *02/15/23
|
Thibaut Mongon
Exec VP, WW Chair, Cons Health
|
Buy
Grant, Award
|
+18.95% | 13,710 | N/A | $0 | |
|
02/13/23
Filed: *02/15/23
|
Thibaut Mongon
Exec VP, WW Chair, Cons Health
|
Sell
For Tax Liability
|
-9.75% | 6,430 | $162.01 | $1,041,724 | |
|
02/13/23
Filed: *02/15/23
|
Ashley Mcevoy
EVP, WW Chair, MedTech
|
Buy
Grant, Award
|
+29.03% | 17,994 | N/A | $0 | |
|
02/13/23
Filed: *02/15/23
|
Ashley Mcevoy
EVP, WW Chair, MedTech
|
Sell
For Tax Liability
|
-13.06% | 7,158 | $162.01 | $1,159,668 | |
|
02/13/23
Filed: *02/15/23
|
William Hait
See Remarks
|
Buy
Grant, Award
|
+10.44% | 9,640 | N/A | $0 | |
|
02/13/23
Filed: *02/15/23
|
William Hait
See Remarks
|
Sell
For Tax Liability
|
-5.23% | 4,586 | $162.01 | $742,978 | |
|
02/13/23
Filed: *02/15/23
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Buy
Grant, Award
|
+9.71% | 12,468 | N/A | $0 | |
|
02/13/23
Filed: *02/15/23
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
For Tax Liability
|
-4.70% | 5,765 | $162.01 | $933,988 | |
|
02/13/23
Filed: *02/15/23
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Grant, Award
|
+9.49% | 31,319 | N/A | $0 | |
|
02/13/23
Filed: *02/15/23
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
For Tax Liability
|
-4.30% | 13,599 | $162.01 | $2,203,174 | |
|
02/13/23
Filed: *02/15/23
|
Robert J Decker
VP Corporate Controller
|
Buy
Grant, Award
|
+8.38% | 1,451 | N/A | $0 | |
|
02/13/23
Filed: *02/15/23
|
Robert J Decker
VP Corporate Controller
|
Sell
For Tax Liability
|
-2.35% | 397 | $162.01 | $64,318 | |
|
02/13/23
Filed: *02/15/23
|
Elizabeth Forminard
Executive VP, General Counsel
|
Buy
Grant, Award
|
+39.87% | 2,555 | N/A | $0 | |
|
02/13/23
Filed: *02/15/23
|
Elizabeth Forminard
Executive VP, General Counsel
|
Sell
For Tax Liability
|
-16.85% | 924 | $162.01 | $149,697 | |
|
02/13/23
Filed: *02/15/23
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Buy
Grant, Award
|
+19.28% | 3,981 | N/A | $0 | |
|
02/13/23
Filed: *02/15/23
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Sell
For Tax Liability
|
-7.50% | 1,440 | $162.01 | $233,294 | |
|
02/10/23
Filed: *02/14/23
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Option Exercised
|
+1.73% | 5,220 | N/A | $0 | |
|
02/10/23
Filed: *02/14/23
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
For Tax Liability
|
-0.76% | 2,267 | $162.08 | $367,435 | |
|
02/10/23
Filed: *02/14/23
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Buy
Option Exercised
|
+2.47% | 1,807 | N/A | $0 | |
|
02/10/23
Filed: *02/14/23
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Sell
For Tax Liability
|
-0.92% | 667 | $162.08 | $108,107 | |
|
02/10/23
Filed: *02/14/23
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+8.78% | 3,449 | N/A | $0 | |
|
02/10/23
Filed: *02/14/23
|
Joseph J Wolk
Exec VP, CFO
|
Sell
For Tax Liability
|
-2.56% | 979 | $162.08 | $158,676 | |
|
02/10/23
Filed: *02/14/23
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Buy
Option Exercised
|
+2.75% | 3,570 | N/A | $0 | |
|
02/10/23
Filed: *02/14/23
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Sell
For Tax Liability
|
-1.00% | 1,289 | $162.08 | $208,921 | |
|
02/10/23
Filed: *02/14/23
|
Ashley Mcevoy
EVP, WW Chair, MedTech
|
Buy
Option Exercised
|
+6.69% | 2,999 | N/A | $0 | |
|
02/10/23
Filed: *02/14/23
|
Ashley Mcevoy
EVP, WW Chair, MedTech
|
Sell
For Tax Liability
|
-1.87% | 823 | $162.08 | $133,392 | |
|
02/10/23
Filed: *02/14/23
|
Elizabeth Forminard
Executive VP, General Counsel
|
Buy
Option Exercised
|
+24.14% | 1,022 | N/A | $0 | |
|
02/10/23
Filed: *02/14/23
|
Elizabeth Forminard
Executive VP, General Counsel
|
Sell
For Tax Liability
|
-9.86% | 380 | $162.08 | $61,590 | |
|
02/10/23
Filed: *02/14/23
|
William Hait
See Remarks
|
Buy
Option Exercised
|
+4.59% | 3,856 | N/A | $0 | |
|
02/10/23
Filed: *02/14/23
|
William Hait
See Remarks
|
Sell
For Tax Liability
|
-1.69% | 1,399 | $162.08 | $226,750 | |
|
02/10/23
Filed: *02/14/23
|
Thibaut Mongon
Exec VP, WW Chair, Cons Health
|
Buy
Option Exercised
|
+3.84% | 2,285 | N/A | $0 | |
|
02/10/23
Filed: *02/14/23
|
Thibaut Mongon
Exec VP, WW Chair, Cons Health
|
Sell
For Tax Liability
|
-1.41% | 826 | $162.08 | $133,878 | |
|
02/10/23
Filed: *02/14/23
|
Robert J Decker
VP Corporate Controller
|
Buy
Option Exercised
|
+3.62% | 581 | N/A | $0 | |
|
02/10/23
Filed: *02/14/23
|
Robert J Decker
VP Corporate Controller
|
Sell
For Tax Liability
|
-1.20% | 191 | $162.08 | $30,957 | |
|
02/10/23
Filed: *02/14/23
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Buy
Option Exercised
|
+9.22% | 1,592 | N/A | $0 | |
|
02/10/23
Filed: *02/14/23
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Sell
For Tax Liability
|
-3.58% | 597 | $162.08 | $96,762 | |
|
02/10/23
Filed: *02/14/23
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Buy
Option Exercised
|
+1.78% | 2,078 | N/A | $0 | |
|
02/10/23
Filed: *02/14/23
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
For Tax Liability
|
-0.66% | 761 | $162.08 | $123,343 | |
|
02/14/22
Filed: *02/14/23
|
James D. Swanson
See Remarks
|
Buy
Option Exercised
|
+15.45% | 1,291 | N/A | $0 | |
|
02/14/22
Filed: *02/14/23
|
James D. Swanson
See Remarks
|
Sell
For Tax Liability
|
-4.87% | 388 | $162.08 | $62,887 | |
|
01/17/23
Filed: *01/18/23
|
Alex Gorsky
|
Buy
Option Exercised
|
+48.33% | 547,692 | $72.54 | $39,729,578 | |
|
01/17/23
Filed: *01/18/23
|
Alex Gorsky
|
Sell
For Tax Liability
|
-47.82% | 366,610 | $173.43 | $63,581,172 | |
|
01/17/23
Filed: *01/18/23
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Option Exercised
|
+37.65% | 148,538 | $72.54 | $10,774,947 | |
|
01/17/23
Filed: *01/18/23
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
For Tax Liability
|
-33.41% | 98,795 | $173.43 | $17,134,017 | |
|
12/13/22
Filed: *12/15/22
|
Joseph J Wolk
Exec VP, CFO
|
Sell
Bona Fide Gift
|
-0.05% | 18 | N/A | $0 | |
|
12/13/22
Filed: *12/15/22
|
Joseph J Wolk
Exec VP, CFO
|
Sell
Bona Fide Gift
|
-0.08% | 28 | N/A | $0 | |
|
12/13/22
Filed: *12/15/22
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+26.52% | 12,926 | $90.44 | $1,169,027 | |
|
12/13/22
Filed: *12/15/22
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+3.67% | 1,855 | $72.54 | $134,562 | |
|
12/13/22
Filed: *12/15/22
|
Joseph J Wolk
Exec VP, CFO
|
Sell
Open Market Sell
|
-3.81% | 1,855 | $179.46 | $332,906 | |
|
12/13/22
Filed: *12/15/22
|
Joseph J Wolk
Exec VP, CFO
|
Sell
Open Market Sell
|
-36.09% | 12,926 | $179.62 | $2,321,755 | |
|
11/30/22
Filed: *12/02/22
|
Ashley Mcevoy
EVP, WW Chair, MedTech
|
Buy
Option Exercised
|
+63.68% | 73,323 | $72.54 | $5,318,850 | |
|
11/30/22
Filed: *12/02/22
|
Ashley Mcevoy
EVP, WW Chair, MedTech
|
Sell
Open Market Sell
|
-1.23% | 1,400 | $176.09 | $246,529 | |
|
11/30/22
Filed: *12/02/22
|
Ashley Mcevoy
EVP, WW Chair, MedTech
|
Sell
Open Market Sell
|
-172.01% | 71,923 | $175.46 | $12,619,272 | |
|
11/22/22
Filed: *11/23/22
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Buy
Option Exercised
|
+37.82% | 76,923 | $72.54 | $5,579,994 | |
|
11/22/22
Filed: *11/23/22
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Sell
Open Market Sell
|
-60.83% | 76,923 | $176.78 | $13,598,402 | |
|
11/18/22
Filed: *11/21/22
|
Robert J Decker
Controller, CAO
|
Buy
Option Exercised
|
+52.25% | 16,928 | $90.44 | $1,530,968 | |
|
11/18/22
Filed: *11/21/22
|
Robert J Decker
Controller, CAO
|
Sell
Open Market Sell
|
-109.40% | 16,928 | $175.00 | $2,962,400 | |
|
11/09/22
Filed: *11/10/22
|
Kathryn E Wengel
EVP, Chief GSC Officer
|
Buy
Option Exercised
|
+18.71% | 16,410 | $72.54 | $1,190,381 | |
|
11/09/22
Filed: *11/10/22
|
Kathryn E Wengel
EVP, Chief GSC Officer
|
Sell
Open Market Sell
|
-23.01% | 16,410 | $173.42 | $2,845,773 | |
|
11/07/22
Filed: *11/09/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Buy
Option Exercised
|
+20.00% | 10,033 | $115.67 | $1,160,517 | - |
|
11/07/22
Filed: *11/09/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Buy
Option Exercised
|
+12.26% | 7,010 | $101.87 | $714,109 | - |
|
11/04/22
Filed: *11/08/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Buy
Option Exercised
|
+31.31% | 18,293 | $131.94 | $2,413,578 | |
|
11/04/22
Filed: *11/08/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Buy
Option Exercised
|
+22.49% | 16,953 | $129.51 | $2,195,583 | |
|
11/04/22
Filed: *11/08/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-29.02% | 16,953 | $171.14 | $2,901,269 | |
|
11/04/22
Filed: *11/08/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-45.58% | 18,293 | $171.22 | $3,132,036 | |
|
11/02/22
Filed: *11/04/22
|
James D. Swanson
EVP, Chief Information Officer
|
Buy
Option Exercised
|
+90.14% | 9,912 | N/A | $0 | |
|
11/02/22
Filed: *11/04/22
|
James D. Swanson
EVP, Chief Information Officer
|
Sell
For Tax Liability
|
-55.66% | 3,932 | $172.29 | $677,444 | |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.58% | 830 | $171.36 | $142,230 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.64% | 900 | $171.36 | $154,226 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.63% | 900 | $171.36 | $154,226 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.65% | 900 | $171.36 | $154,226 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.65% | 900 | $171.36 | $154,226 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.64% | 900 | $171.36 | $154,226 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.65% | 901 | $171.36 | $154,397 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.68% | 927 | $171.36 | $158,853 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.69% | 943 | $171.36 | $161,594 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.71% | 963 | $171.36 | $165,022 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.75% | 1,000 | $171.36 | $171,362 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.75% | 1,000 | $171.36 | $171,362 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.81% | 1,073 | $171.36 | $183,871 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.83% | 1,088 | $171.36 | $186,442 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.85% | 1,100 | $171.36 | $188,498 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.90% | 1,159 | $171.36 | $198,609 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.93% | 1,180 | $171.36 | $202,207 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-1.01% | 1,271 | $171.36 | $217,801 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-1.12% | 1,390 | $171.36 | $238,193 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-1.19% | 1,462 | $171.36 | $250,531 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-1.23% | 1,499 | $171.36 | $256,872 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-1.28% | 1,540 | $171.36 | $263,897 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-1.48% | 1,757 | $171.36 | $301,083 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-1.53% | 1,780 | $171.36 | $305,024 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-1.67% | 1,912 | $171.36 | $327,644 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.32% | 529 | $171.36 | $90,650 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.33% | 534 | $171.36 | $91,507 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.34% | 556 | $170.76 | $94,944 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.36% | 582 | $170.76 | $99,383 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.37% | 600 | $171.36 | $102,817 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.37% | 600 | $170.76 | $102,457 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.37% | 600 | $170.76 | $102,457 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.38% | 613 | $171.36 | $105,045 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.39% | 623 | $170.76 | $106,385 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.40% | 641 | $171.36 | $109,843 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.41% | 643 | $171.36 | $110,186 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.44% | 690 | $171.36 | $118,240 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.44% | 698 | $170.76 | $119,192 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.45% | 700 | $171.36 | $119,953 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.45% | 700 | $171.36 | $119,953 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.45% | 700 | $170.76 | $119,533 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.46% | 703 | $170.76 | $120,046 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.47% | 725 | $171.36 | $124,237 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.49% | 745 | $171.36 | $127,665 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.49% | 746 | $171.36 | $127,836 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.50% | 750 | $171.36 | $128,522 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.51% | 769 | $171.36 | $131,777 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.52% | 780 | $171.36 | $133,662 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.53% | 789 | $170.76 | $134,731 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.54% | 794 | $171.36 | $136,061 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.54% | 800 | $171.36 | $137,090 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.55% | 800 | $171.36 | $137,090 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.55% | 800 | $171.36 | $137,090 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.56% | 816 | $171.36 | $139,831 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.57% | 825 | $171.36 | $141,374 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.21% | 372 | $170.76 | $63,523 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.21% | 380 | $171.36 | $65,118 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.22% | 386 | $171.36 | $66,146 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.23% | 400 | $171.36 | $68,545 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.23% | 400 | $171.36 | $68,545 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.23% | 400 | $171.36 | $68,545 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.23% | 400 | $171.36 | $68,545 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.23% | 400 | $171.36 | $68,545 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.23% | 400 | $171.36 | $68,545 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.23% | 400 | $171.36 | $68,545 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.23% | 400 | $171.36 | $68,545 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.23% | 400 | $171.36 | $68,545 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.23% | 400 | $171.36 | $68,545 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.23% | 400 | $171.36 | $68,545 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.23% | 400 | $171.36 | $68,545 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.23% | 400 | $170.76 | $68,305 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.23% | 400 | $170.76 | $68,305 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.23% | 400 | $170.76 | $68,305 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.25% | 419 | $170.76 | $71,549 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.26% | 443 | $171.36 | $75,913 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.28% | 470 | $171.36 | $80,540 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.28% | 478 | $171.36 | $81,911 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.30% | 498 | $171.36 | $85,338 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.30% | 500 | $171.36 | $85,681 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.30% | 500 | $171.36 | $85,681 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.30% | 500 | $171.36 | $85,681 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.30% | 500 | $171.36 | $85,681 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.30% | 500 | $170.76 | $85,381 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.32% | 525 | $170.76 | $89,650 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.32% | 527 | $171.36 | $90,308 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.11% | 200 | $171.36 | $34,272 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.11% | 200 | $171.36 | $34,272 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.11% | 200 | $171.36 | $34,272 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.11% | 200 | $171.36 | $34,272 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.11% | 200 | $171.36 | $34,272 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.11% | 200 | $170.76 | $34,152 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.11% | 200 | $170.76 | $34,152 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.14% | 261 | $170.76 | $44,569 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.16% | 295 | $171.36 | $50,552 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.16% | 300 | $172.00 | $51,601 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.17% | 300 | $171.36 | $51,409 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.16% | 300 | $171.36 | $51,409 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.17% | 300 | $171.36 | $51,409 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.16% | 300 | $171.36 | $51,409 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.17% | 300 | $171.36 | $51,409 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.16% | 300 | $171.36 | $51,409 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.17% | 300 | $171.36 | $51,409 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.16% | 300 | $171.36 | $51,409 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.17% | 300 | $171.36 | $51,409 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.16% | 300 | $171.36 | $51,409 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.16% | 300 | $171.36 | $51,409 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.17% | 300 | $170.76 | $51,229 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.17% | 300 | $170.76 | $51,229 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.17% | 300 | $170.76 | $51,229 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.17% | 300 | $170.76 | $51,229 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.17% | 300 | $170.76 | $51,229 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.17% | 300 | $170.76 | $51,229 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.17% | 300 | $170.76 | $51,229 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.17% | 300 | $170.76 | $51,229 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.17% | 300 | $170.76 | $51,229 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $172.00 | $17,200 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $171.36 | $17,136 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $171.36 | $17,136 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $171.36 | $17,136 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $171.36 | $17,136 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $171.36 | $17,136 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $171.36 | $17,136 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $171.36 | $17,136 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $171.36 | $17,136 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $170.76 | $17,076 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $170.76 | $17,076 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $170.76 | $17,076 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $170.76 | $17,076 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $170.76 | $17,076 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $170.76 | $17,076 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $170.76 | $17,076 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.06% | 105 | $170.76 | $17,930 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.09% | 162 | $170.76 | $27,663 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.10% | 196 | $171.36 | $33,587 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.11% | 200 | $171.36 | $34,272 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.11% | 200 | $171.36 | $34,272 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.11% | 200 | $171.36 | $34,272 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.11% | 200 | $171.36 | $34,272 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.11% | 200 | $171.36 | $34,272 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.11% | 200 | $171.36 | $34,272 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.11% | 200 | $171.36 | $34,272 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.11% | 200 | $170.76 | $34,152 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.11% | 200 | $170.76 | $34,152 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.11% | 200 | $170.76 | $34,152 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.11% | 200 | $170.76 | $34,152 | - |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Buy
Option Exercised
|
+40.62% | 78,458 | $115.67 | $9,075,237 | |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.01% | 26 | $171.36 | $4,455 | |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 91 | $170.76 | $15,539 | |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 98 | $171.36 | $16,793 | |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $171.36 | $17,136 | |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $171.36 | $17,136 | |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $171.36 | $17,136 | |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $171.36 | $17,136 | |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $171.36 | $17,136 | |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $171.36 | $17,136 | |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $171.36 | $17,136 | |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $171.36 | $17,136 | |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $171.36 | $17,136 | |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $171.36 | $17,136 | |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $171.36 | $17,136 | |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $170.76 | $17,076 | |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $170.76 | $17,076 | |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $170.76 | $17,076 | |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $170.76 | $17,076 | |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $170.76 | $17,076 | |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $170.76 | $17,076 | |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $170.76 | $17,076 | |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $170.76 | $17,076 | |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $170.76 | $17,076 | |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $170.76 | $17,076 | |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $170.76 | $17,076 | |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $170.76 | $17,076 | |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $170.76 | $17,076 | |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $170.76 | $17,076 | |
|
10/24/22
Filed: *10/26/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $170.76 | $17,076 | |
|
10/24/22
Filed: *10/26/22
|
William Hait
See Remarks
|
Buy
Option Exercised
|
+15.75% | 15,000 | $90.44 | $1,356,600 | |
|
10/24/22
Filed: *10/26/22
|
William Hait
See Remarks
|
Sell
Open Market Sell
|
-1.26% | 1,187 | $171.55 | $203,627 | |
|
10/24/22
Filed: *10/26/22
|
William Hait
See Remarks
|
Sell
Open Market Sell
|
-17.22% | 13,813 | $171.55 | $2,369,593 | |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.94% | 1,300 | $164.50 | $213,854 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-1.00% | 1,354 | $164.50 | $222,737 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-1.05% | 1,400 | $164.50 | $230,304 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-1.06% | 1,400 | $164.50 | $230,304 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-1.07% | 1,401 | $164.50 | $230,469 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-1.09% | 1,415 | $164.50 | $232,772 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-1.16% | 1,480 | $164.50 | $243,464 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-1.29% | 1,633 | $164.50 | $268,633 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-1.34% | 1,668 | $164.50 | $274,391 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-1.53% | 1,878 | $164.50 | $308,937 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-1.56% | 1,887 | $164.50 | $310,417 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-1.59% | 1,891 | $164.50 | $311,075 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-1.65% | 1,926 | $164.50 | $316,833 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-1.95% | 2,231 | $164.50 | $367,006 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.48% | 800 | $164.50 | $131,602 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.48% | 800 | $164.50 | $131,602 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.48% | 800 | $164.50 | $131,602 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.49% | 800 | $164.50 | $131,602 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.49% | 800 | $164.50 | $131,602 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.49% | 803 | $164.50 | $132,096 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.50% | 813 | $164.50 | $133,741 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.53% | 846 | $164.50 | $139,170 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.56% | 890 | $164.50 | $146,408 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.57% | 900 | $164.50 | $148,053 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.57% | 905 | $164.50 | $148,875 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.58% | 913 | $164.50 | $150,191 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.59% | 922 | $164.50 | $151,672 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.60% | 926 | $164.50 | $152,330 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.60% | 929 | $164.50 | $152,823 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.65% | 1,000 | $164.50 | $164,503 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.66% | 1,004 | $164.50 | $165,161 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.67% | 1,016 | $164.50 | $167,135 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.68% | 1,026 | $164.50 | $168,780 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.71% | 1,063 | $164.50 | $174,867 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.74% | 1,100 | $164.50 | $180,953 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.76% | 1,125 | $164.50 | $185,066 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.77% | 1,131 | $164.50 | $186,053 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.80% | 1,157 | $164.50 | $190,330 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.83% | 1,200 | $164.50 | $197,404 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.84% | 1,200 | $164.50 | $197,404 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.85% | 1,202 | $164.50 | $197,733 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.91% | 1,275 | $164.50 | $209,741 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.95% | 1,300 | $164.50 | $213,854 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.95% | 1,300 | $164.50 | $213,854 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.11% | 206 | $164.50 | $33,888 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.12% | 224 | $164.50 | $36,849 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.14% | 261 | $164.50 | $42,935 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.17% | 300 | $164.50 | $49,351 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.17% | 300 | $164.50 | $49,351 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.17% | 300 | $164.50 | $49,351 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.17% | 300 | $164.50 | $49,351 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.17% | 300 | $164.50 | $49,351 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.19% | 344 | $164.50 | $56,589 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.22% | 387 | $164.50 | $63,663 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.22% | 390 | $164.50 | $64,156 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.22% | 390 | $164.50 | $64,156 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.23% | 400 | $164.50 | $65,801 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.23% | 400 | $164.50 | $65,801 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.23% | 400 | $164.50 | $65,801 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.23% | 400 | $164.50 | $65,801 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.23% | 400 | $164.50 | $65,801 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.23% | 400 | $164.50 | $65,801 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.28% | 484 | $164.50 | $79,619 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.29% | 500 | $164.50 | $82,252 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.29% | 500 | $164.50 | $82,252 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.32% | 550 | $164.50 | $90,477 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.34% | 590 | $164.50 | $97,057 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.35% | 600 | $164.50 | $98,702 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.35% | 600 | $164.50 | $98,702 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.41% | 700 | $164.50 | $115,152 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.41% | 700 | $164.50 | $115,152 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.47% | 790 | $164.50 | $129,957 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.47% | 793 | $164.50 | $130,451 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.47% | 794 | $164.50 | $130,615 | - |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Buy
Option Exercised
|
+37.95% | 70,126 | $101.87 | $7,143,736 | |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.02% | 35 | $164.50 | $5,758 | |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.03% | 64 | $164.50 | $10,528 | |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 89 | $164.50 | $14,641 | |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 90 | $164.50 | $14,805 | |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $164.50 | $16,450 | |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $164.50 | $16,450 | |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $164.50 | $16,450 | |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $164.50 | $16,450 | |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $164.50 | $16,450 | |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $164.50 | $16,450 | |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $164.50 | $16,450 | |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $164.50 | $16,450 | |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $164.50 | $16,450 | |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $164.50 | $16,450 | |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $164.50 | $16,450 | |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $164.50 | $16,450 | |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $164.50 | $16,450 | |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $164.50 | $16,450 | |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.05% | 100 | $164.50 | $16,450 | |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.07% | 127 | $164.50 | $20,892 | |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.07% | 128 | $164.50 | $21,056 | |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.10% | 190 | $164.50 | $31,256 | |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.10% | 190 | $164.50 | $31,256 | |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.11% | 200 | $164.50 | $32,901 | |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.11% | 200 | $164.50 | $32,901 | |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.11% | 200 | $164.50 | $32,901 | |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.11% | 200 | $164.50 | $32,901 | |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.11% | 200 | $164.50 | $32,901 | |
|
10/19/22
Filed: *10/21/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-0.11% | 200 | $164.50 | $32,901 | |
|
06/10/22
Filed: *06/14/22
|
Kathryn E Wengel
EVP, Chief GSC Officer
|
Buy
Option Exercised
|
+35.94% | 40,000 | $72.54 | $2,901,600 | |
|
06/10/22
Filed: *06/14/22
|
Kathryn E Wengel
EVP, Chief GSC Officer
|
Sell
Open Market Sell
|
-0.09% | 100 | $173.00 | $17,300 | |
|
06/10/22
Filed: *06/14/22
|
Kathryn E Wengel
EVP, Chief GSC Officer
|
Sell
Open Market Sell
|
-0.16% | 174 | $173.00 | $30,102 | |
|
06/10/22
Filed: *06/14/22
|
Kathryn E Wengel
EVP, Chief GSC Officer
|
Sell
Open Market Sell
|
-6.32% | 6,600 | $173.00 | $1,141,807 | |
|
06/10/22
Filed: *06/14/22
|
Kathryn E Wengel
EVP, Chief GSC Officer
|
Sell
Open Market Sell
|
-46.45% | 33,126 | $173.00 | $5,730,831 | |
|
05/26/22
Filed: *05/31/22
|
Robert J Decker
Controller, CAO
|
Buy
Option Exercised
|
+35.35% | 8,462 | $72.54 | $613,833 | |
|
05/26/22
Filed: *05/31/22
|
Robert J Decker
Controller, CAO
|
Sell
Open Market Sell
|
-54.69% | 8,462 | $180.00 | $1,523,160 | |
|
04/21/22
Filed: *04/25/22
|
William Hait
See Remarks
|
Buy
Option Exercised
|
+27.02% | 29,699 | $90.44 | $2,685,978 | |
|
04/21/22
Filed: *04/25/22
|
William Hait
See Remarks
|
Sell
Open Market Sell
|
-0.09% | 100 | $183.58 | $18,358 | |
|
04/21/22
Filed: *04/25/22
|
William Hait
See Remarks
|
Sell
Open Market Sell
|
-0.09% | 100 | $183.58 | $18,358 | |
|
04/21/22
Filed: *04/25/22
|
William Hait
See Remarks
|
Sell
Open Market Sell
|
-0.21% | 225 | $183.58 | $41,305 | |
|
04/21/22
Filed: *04/25/22
|
William Hait
See Remarks
|
Sell
Open Market Sell
|
-0.64% | 700 | $183.58 | $128,504 | |
|
04/21/22
Filed: *04/25/22
|
William Hait
See Remarks
|
Sell
Open Market Sell
|
-1.31% | 1,403 | $183.58 | $257,559 | |
|
04/21/22
Filed: *04/25/22
|
William Hait
See Remarks
|
Sell
Open Market Sell
|
-1.60% | 1,696 | $183.58 | $311,347 | |
|
04/21/22
Filed: *04/25/22
|
William Hait
See Remarks
|
Sell
Open Market Sell
|
-2.80% | 2,884 | $183.58 | $529,436 | |
|
04/21/22
Filed: *04/25/22
|
William Hait
See Remarks
|
Sell
Open Market Sell
|
-28.16% | 22,591 | $183.58 | $4,147,188 | |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-2.28% | 1,420 | $176.28 | $250,313 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-2.73% | 1,657 | $176.28 | $292,091 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-2.94% | 1,735 | $176.28 | $305,841 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-3.07% | 1,757 | $176.28 | $309,719 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-3.35% | 1,856 | $176.28 | $327,170 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-3.70% | 1,976 | $176.28 | $348,323 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-5.83% | 2,944 | $176.28 | $518,959 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-8.07% | 3,770 | $176.16 | $664,123 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-16.36% | 6,566 | $176.24 | $1,157,179 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Buy
Option Exercised
|
+31.28% | 19,985 | $100.06 | $1,999,699 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Buy
Option Exercised
|
+14.46% | 10,800 | $101.87 | $1,100,196 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-0.01% | 6 | $176.28 | $1,058 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-0.01% | 9 | $176.28 | $1,586 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-0.01% | 10 | $176.28 | $1,763 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-0.06% | 45 | $176.28 | $7,932 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-0.06% | 45 | $176.28 | $7,932 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-0.08% | 57 | $176.28 | $10,048 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-0.08% | 57 | $176.28 | $10,048 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-0.13% | 97 | $176.28 | $17,099 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-0.13% | 100 | $176.28 | $17,628 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-0.19% | 143 | $176.28 | $25,208 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-0.21% | 157 | $176.28 | $27,675 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-0.27% | 200 | $176.24 | $35,248 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-0.31% | 227 | $176.24 | $40,006 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-0.51% | 373 | $176.24 | $65,737 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-0.64% | 464 | $176.24 | $81,774 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-0.66% | 477 | $176.28 | $84,084 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-0.68% | 487 | $176.28 | $85,847 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-0.77% | 550 | $176.24 | $96,931 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-0.78% | 551 | $176.24 | $97,107 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-0.79% | 555 | $176.24 | $97,812 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-0.86% | 596 | $176.28 | $105,061 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-0.87% | 597 | $176.24 | $105,214 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-0.90% | 613 | $176.28 | $108,058 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-1.06% | 717 | $176.24 | $126,363 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-1.25% | 833 | $176.28 | $146,839 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-1.29% | 848 | $176.28 | $149,483 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-1.47% | 957 | $176.28 | $168,697 | - |
|
03/17/22
Filed: *03/21/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-1.73% | 1,103 | $176.28 | $194,434 | - |
|
03/15/22
Filed: *03/17/22
|
Robert J Decker
Controller, CAO
|
Buy
Option Exercised
|
+24.42% | 5,000 | $72.54 | $362,700 | |
|
03/15/22
Filed: *03/17/22
|
Robert J Decker
Controller, CAO
|
Sell
Open Market Sell
|
-1.24% | 250 | $175.51 | $43,876 | |
|
03/15/22
Filed: *03/17/22
|
Robert J Decker
Controller, CAO
|
Sell
Open Market Sell
|
-10.98% | 2,000 | $175.51 | $351,012 | |
|
03/15/22
Filed: *03/17/22
|
Robert J Decker
Controller, CAO
|
Sell
Open Market Sell
|
-17.77% | 2,750 | $175.51 | $482,642 | |
|
02/14/22
Filed: *02/18/22
|
William Hait
See Remarks
|
Buy
Option Exercised
|
+9.63% | 8,128 | N/A | $0 | |
|
02/14/22
Filed: *02/18/22
|
William Hait
See Remarks
|
Sell
For Tax Liability
|
-5.18% | 4,158 | $165.89 | $689,771 | |
|
02/14/22
Filed: *02/17/22
|
Robert J Decker
Controller, CAO
|
Buy
Option Exercised
|
+5.74% | 903 | N/A | $0 | |
|
02/14/22
Filed: *02/17/22
|
Robert J Decker
Controller, CAO
|
Sell
For Tax Liability
|
-1.60% | 248 | $165.89 | $41,141 | |
|
02/14/22
Filed: *02/17/22
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Buy
Option Exercised
|
+13.35% | 18,064 | N/A | $0 | |
|
02/14/22
Filed: *02/17/22
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Sell
For Tax Liability
|
-6.99% | 8,841 | $165.89 | $1,466,633 | |
|
02/14/22
Filed: *02/17/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Buy
Option Exercised
|
+8.57% | 3,922 | N/A | $0 | |
|
02/14/22
Filed: *02/17/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
For Tax Liability
|
-4.20% | 1,843 | $165.89 | $305,735 | |
|
02/14/22
Filed: *02/17/22
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+41.21% | 17,793 | N/A | $0 | |
|
02/14/22
Filed: *02/17/22
|
Joseph J Wolk
Exec VP, CFO
|
Sell
For Tax Liability
|
-20.41% | 7,319 | $165.89 | $1,214,149 | |
|
02/14/22
Filed: *02/17/22
|
Kathryn E Wengel
EVP, Chief GSC Officer
|
Buy
Option Exercised
|
+13.66% | 10,386 | N/A | $0 | |
|
02/14/22
Filed: *02/17/22
|
Kathryn E Wengel
EVP, Chief GSC Officer
|
Sell
For Tax Liability
|
-6.59% | 4,699 | $165.89 | $779,517 | |
|
02/14/22
Filed: *02/17/22
|
Ashley Mcevoy
EVP, WW Chair, Medical Devices
|
Buy
Option Exercised
|
+32.89% | 15,806 | N/A | $0 | |
|
02/14/22
Filed: *02/17/22
|
Ashley Mcevoy
EVP, WW Chair, Medical Devices
|
Sell
For Tax Liability
|
-14.93% | 6,242 | $165.89 | $1,035,485 | |
|
02/14/22
Filed: *02/17/22
|
Mathai Mammen
EVP, Pharm, R&D
|
Buy
Option Exercised
|
+17.09% | 7,740 | N/A | $0 | |
|
02/14/22
Filed: *02/17/22
|
Mathai Mammen
EVP, Pharm, R&D
|
Sell
For Tax Liability
|
-8.03% | 3,366 | $165.89 | $558,386 | |
|
02/14/22
Filed: *02/17/22
|
Alex Gorsky
|
Buy
Option Exercised
|
+9.96% | 60,965 | N/A | $0 | |
|
02/14/22
Filed: *02/17/22
|
Alex Gorsky
|
Sell
For Tax Liability
|
-4.52% | 26,472 | $165.89 | $4,391,440 | |
|
02/14/22
Filed: *02/17/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Buy
Option Exercised
|
+9.41% | 11,154 | N/A | $0 | |
|
02/14/22
Filed: *02/17/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
For Tax Liability
|
-4.46% | 5,114 | $165.89 | $848,361 | |
|
02/14/22
Filed: *02/17/22
|
Joaquin Duato
CEO
|
Buy
Option Exercised
|
+11.48% | 29,714 | N/A | $0 | |
|
02/14/22
Filed: *02/17/22
|
Joaquin Duato
CEO
|
Sell
For Tax Liability
|
-5.25% | 12,902 | $165.89 | $2,140,313 | |
|
02/14/22
Filed: *02/17/22
|
Vanessa Broadhurst
EVP, Global Corp Aff.
|
Buy
Option Exercised
|
+15.41% | 2,557 | N/A | $0 | |
|
02/14/22
Filed: *02/17/22
|
Vanessa Broadhurst
EVP, Global Corp Aff.
|
Sell
For Tax Liability
|
-5.90% | 925 | $165.89 | $153,448 | |
|
02/14/22
Filed: *02/17/22
|
Michael H Ullmann
Exec VP, General Counsel
|
Buy
Option Exercised
|
+7.99% | 13,186 | N/A | $0 | |
|
02/14/22
Filed: *02/17/22
|
Michael H Ullmann
Exec VP, General Counsel
|
Sell
For Tax Liability
|
-3.91% | 6,209 | $165.89 | $1,030,011 | |
|
02/14/22
Filed: *02/15/22
|
Alex Gorsky
|
Buy
Option Exercised
|
+2.00% | 11,129 | N/A | $0 | |
|
02/14/22
Filed: *02/15/22
|
Alex Gorsky
|
Sell
For Tax Liability
|
-0.88% | 4,833 | $168.85 | $816,052 | |
|
02/14/22
Filed: *02/15/22
|
Joaquin Duato
CEO
|
Buy
Option Exercised
|
+2.34% | 5,424 | N/A | $0 | |
|
02/14/22
Filed: *02/15/22
|
Joaquin Duato
CEO
|
Sell
For Tax Liability
|
-1.03% | 2,356 | $168.85 | $397,811 | |
|
02/14/22
Filed: *02/15/22
|
William Hait
See Remarks
|
Buy
Option Exercised
|
+3.37% | 7,790 | N/A | $0 | |
|
02/14/22
Filed: *02/15/22
|
William Hait
See Remarks
|
Sell
For Tax Liability
|
-1.38% | 3,133 | $168.85 | $529,007 | |
|
02/14/22
Filed: *02/15/22
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+12.35% | 3,248 | N/A | $0 | |
|
02/14/22
Filed: *02/15/22
|
Joseph J Wolk
Exec VP, CFO
|
Sell
For Tax Liability
|
-3.63% | 921 | $168.85 | $155,511 | |
|
02/14/22
Filed: *02/15/22
|
Mathai Mammen
EVP, Pharm, R&D
|
Buy
Option Exercised
|
+18.59% | 7,418 | N/A | $0 | |
|
02/14/22
Filed: *02/15/22
|
Mathai Mammen
EVP, Pharm, R&D
|
Sell
For Tax Liability
|
-6.22% | 2,335 | $168.85 | $394,265 | |
|
02/14/22
Filed: *02/15/22
|
Kathryn E Wengel
EVP, Chief GSC Officer
|
Buy
Option Exercised
|
+2.86% | 1,896 | N/A | $0 | |
|
02/14/22
Filed: *02/15/22
|
Kathryn E Wengel
EVP, Chief GSC Officer
|
Sell
For Tax Liability
|
-1.06% | 695 | $168.85 | $117,351 | |
|
02/14/22
Filed: *02/15/22
|
Vanessa Broadhurst
EVP, Global Corp Aff.
|
Buy
Option Exercised
|
+16.41% | 2,451 | N/A | $0 | |
|
02/14/22
Filed: *02/15/22
|
Vanessa Broadhurst
EVP, Global Corp Aff.
|
Sell
For Tax Liability
|
-6.43% | 902 | $168.85 | $152,303 | |
|
02/14/22
Filed: *02/15/22
|
Michael H Ullmann
Exec VP, General Counsel
|
Sell
Bona Fide Gift
|
-0.20% | 304 | N/A | $0 | |
|
02/14/22
Filed: *02/15/22
|
Michael H Ullmann
Exec VP, General Counsel
|
Sell
Bona Fide Gift
|
-0.40% | 608 | N/A | $0 | |
|
02/14/22
Filed: *02/15/22
|
Michael H Ullmann
Exec VP, General Counsel
|
Buy
Option Exercised
|
+1.58% | 2,407 | N/A | $0 | |
|
02/14/22
Filed: *02/15/22
|
Michael H Ullmann
Exec VP, General Counsel
|
Sell
For Tax Liability
|
-0.57% | 871 | $168.85 | $147,068 | |
|
02/14/22
Filed: *02/15/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Buy
Option Exercised
|
+8.67% | 3,759 | N/A | $0 | |
|
02/14/22
Filed: *02/15/22
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
For Tax Liability
|
-3.63% | 1,520 | $168.85 | $256,652 | |
|
02/14/22
Filed: *02/15/22
|
Ashley Mcevoy
EVP, WW Chair, Medical Devices
|
Buy
Option Exercised
|
+8.73% | 2,885 | N/A | $0 | |
|
02/14/22
Filed: *02/15/22
|
Ashley Mcevoy
EVP, WW Chair, Medical Devices
|
Sell
For Tax Liability
|
-2.46% | 792 | $168.85 | $133,729 | |
|
02/14/22
Filed: *02/15/22
|
Robert J Decker
Controller, CAO
|
Buy
Option Exercised
|
+5.74% | 866 | N/A | $0 | |
|
02/14/22
Filed: *02/15/22
|
Robert J Decker
Controller, CAO
|
Sell
For Tax Liability
|
-1.77% | 263 | $168.85 | $44,408 | |
|
02/14/22
Filed: *02/15/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Buy
Option Exercised
|
+1.86% | 2,036 | N/A | $0 | |
|
02/14/22
Filed: *02/15/22
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
For Tax Liability
|
-0.68% | 743 | $168.85 | $125,456 | |
|
02/14/22
Filed: *02/15/22
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Buy
Option Exercised
|
+2.78% | 3,297 | N/A | $0 | |
|
02/14/22
Filed: *02/15/22
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Sell
For Tax Liability
|
-1.02% | 1,190 | $168.85 | $200,932 | |
|
01/14/22
Filed: *01/19/22
|
Alex Gorsky
|
Sell
Bona Fide Gift
|
-1.34% | 6,320 | N/A | $0 | |
|
01/14/22
Filed: *01/19/22
|
Alex Gorsky
|
Sell
Bona Fide Gift
|
-1.36% | 6,320 | N/A | $0 | |
|
01/14/22
Filed: *01/19/22
|
Alex Gorsky
|
Buy
Option Exercised
|
+33.35% | 231,951 | $65.37 | $15,162,637 | |
|
01/14/22
Filed: *01/19/22
|
Alex Gorsky
|
Sell
For Tax Liability
|
-27.71% | 150,943 | $167.84 | $25,334,273 | |
|
01/14/22
Filed: *01/19/22
|
Joaquin Duato
CEO
|
Buy
Option Exercised
|
+30.10% | 84,423 | $65.37 | $5,518,732 | |
|
01/14/22
Filed: *01/19/22
|
Joaquin Duato
CEO
|
Sell
For Tax Liability
|
-24.05% | 54,378 | $167.84 | $9,126,804 | |
|
12/07/21
Filed: *12/09/21
|
Robert J Decker
Controller, CAO
|
Buy
Option Exercised
|
+26.02% | 5,000 | $72.54 | $362,700 | |
|
12/07/21
Filed: *12/09/21
|
Robert J Decker
Controller, CAO
|
Sell
Open Market Sell
|
-35.17% | 5,000 | $163.21 | $816,050 | |
|
02/12/21
Filed: *02/17/21
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Buy
Option Exercised
|
+9.07% | 3,573 | N/A | $0 | |
|
02/12/21
Filed: *02/17/21
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Buy
Option Exercised
|
+8.31% | 3,572 | N/A | $0 | |
|
02/12/21
Filed: *02/17/21
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
For Tax Liability
|
-3.43% | 1,425 | $165.55 | $235,909 | |
|
02/12/21
Filed: *02/17/21
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
For Tax Liability
|
-4.93% | 1,950 | $165.55 | $322,822 | |
|
02/12/21
Filed: *02/17/21
|
Alex Gorsky
Chairman, CEO
|
Buy
Option Exercised
|
+12.72% | 63,088 | N/A | $0 | |
|
02/12/21
Filed: *02/17/21
|
Alex Gorsky
Chairman, CEO
|
Buy
Option Exercised
|
+2.37% | 12,017 | N/A | $0 | |
|
02/12/21
Filed: *02/17/21
|
Alex Gorsky
Chairman, CEO
|
Sell
For Tax Liability
|
-0.86% | 4,313 | $165.55 | $714,017 | |
|
02/12/21
Filed: *02/17/21
|
Alex Gorsky
Chairman, CEO
|
Sell
For Tax Liability
|
-5.75% | 27,393 | $165.55 | $4,534,911 | |
|
02/12/21
Filed: *02/17/21
|
Robert J Decker
Controller, CAO
|
Buy
Option Exercised
|
+4.66% | 655 | N/A | $0 | |
|
02/12/21
Filed: *02/17/21
|
Robert J Decker
Controller, CAO
|
Buy
Option Exercised
|
+4.46% | 655 | N/A | $0 | |
|
02/12/21
Filed: *02/17/21
|
Robert J Decker
Controller, CAO
|
Sell
For Tax Liability
|
-1.55% | 225 | $165.55 | $37,249 | |
|
02/12/21
Filed: *02/17/21
|
Robert J Decker
Controller, CAO
|
Sell
For Tax Liability
|
-1.84% | 261 | $165.55 | $43,209 | |
|
02/12/21
Filed: *02/17/21
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+11.57% | 2,543 | N/A | $0 | |
|
02/12/21
Filed: *02/17/21
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+10.37% | 2,543 | N/A | $0 | |
|
02/12/21
Filed: *02/17/21
|
Joseph J Wolk
Exec VP, CFO
|
Sell
For Tax Liability
|
-3.04% | 723 | $165.55 | $119,693 | |
|
02/12/21
Filed: *02/17/21
|
Joseph J Wolk
Exec VP, CFO
|
Sell
For Tax Liability
|
-3.18% | 733 | $165.55 | $121,348 | |
|
02/12/21
Filed: *02/17/21
|
Kathryn E Wengel
EVP, Chief GSC Officer
|
Buy
Option Exercised
|
+12.96% | 8,704 | N/A | $0 | |
|
02/12/21
Filed: *02/17/21
|
Kathryn E Wengel
EVP, Chief GSC Officer
|
Buy
Option Exercised
|
+2.41% | 1,658 | N/A | $0 | |
|
02/12/21
Filed: *02/17/21
|
Kathryn E Wengel
EVP, Chief GSC Officer
|
Sell
For Tax Liability
|
-0.91% | 618 | $165.55 | $102,310 | |
|
02/12/21
Filed: *02/17/21
|
Kathryn E Wengel
EVP, Chief GSC Officer
|
Sell
For Tax Liability
|
-5.89% | 3,796 | $165.55 | $628,428 | |
|
02/12/21
Filed: *02/17/21
|
Michael H Ullmann
Exec VP, General Counsel
|
Buy
Option Exercised
|
+7.81% | 12,133 | N/A | $0 | |
|
02/12/21
Filed: *02/17/21
|
Michael H Ullmann
Exec VP, General Counsel
|
Buy
Option Exercised
|
+1.47% | 2,311 | N/A | $0 | |
|
02/12/21
Filed: *02/17/21
|
Michael H Ullmann
Exec VP, General Counsel
|
Sell
For Tax Liability
|
-0.54% | 846 | $165.55 | $140,055 | |
|
02/12/21
Filed: *02/17/21
|
Michael H Ullmann
Exec VP, General Counsel
|
Sell
For Tax Liability
|
-3.73% | 5,648 | $165.55 | $935,026 | |
|
02/12/21
Filed: *02/17/21
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Buy
Option Exercised
|
+9.60% | 11,429 | N/A | $0 | |
|
02/12/21
Filed: *02/17/21
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Buy
Option Exercised
|
+1.80% | 2,177 | N/A | $0 | |
|
02/12/21
Filed: *02/17/21
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Sell
For Tax Liability
|
-0.66% | 797 | $165.55 | $131,943 | |
|
02/12/21
Filed: *02/17/21
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Sell
For Tax Liability
|
-4.58% | 5,268 | $165.55 | $872,117 | |
|
02/12/21
Filed: *02/17/21
|
Paulus Stoffels
Vice Chair, Exec Committee
|
Buy
Option Exercised
|
+10.36% | 29,452 | N/A | $0 | |
|
02/12/21
Filed: *02/17/21
|
Paulus Stoffels
Vice Chair, Exec Committee
|
Buy
Option Exercised
|
+1.94% | 5,610 | N/A | $0 | |
|
02/12/21
Filed: *02/17/21
|
Paulus Stoffels
Vice Chair, Exec Committee
|
Sell
For Tax Liability
|
-0.55% | 1,592 | $165.55 | $263,556 | |
|
02/12/21
Filed: *02/17/21
|
Paulus Stoffels
Vice Chair, Exec Committee
|
Sell
For Tax Liability
|
-4.62% | 12,725 | $165.55 | $2,106,624 | |
|
02/12/21
Filed: *02/17/21
|
Ashley Mcevoy
EVP, WW Chair, Medical Devices
|
Buy
Option Exercised
|
+33.71% | 11,034 | N/A | $0 | |
|
02/12/21
Filed: *02/17/21
|
Ashley Mcevoy
EVP, WW Chair, Medical Devices
|
Buy
Option Exercised
|
+6.03% | 2,102 | N/A | $0 | |
|
02/12/21
Filed: *02/17/21
|
Ashley Mcevoy
EVP, WW Chair, Medical Devices
|
Sell
For Tax Liability
|
-1.72% | 588 | $165.55 | $97,343 | |
|
02/12/21
Filed: *02/17/21
|
Ashley Mcevoy
EVP, WW Chair, Medical Devices
|
Sell
For Tax Liability
|
-13.56% | 4,090 | $165.55 | $677,100 | |
|
02/12/21
Filed: *02/17/21
|
Michael E Sneed
EVP, Global Corp Aff & CCO
|
Buy
Option Exercised
|
+12.12% | 7,737 | N/A | $0 | |
|
02/12/21
Filed: *02/17/21
|
Michael E Sneed
EVP, Global Corp Aff & CCO
|
Buy
Option Exercised
|
+2.26% | 1,474 | N/A | $0 | |
|
02/12/21
Filed: *02/17/21
|
Michael E Sneed
EVP, Global Corp Aff & CCO
|
Sell
For Tax Liability
|
-0.67% | 437 | $165.55 | $72,345 | |
|
02/12/21
Filed: *02/17/21
|
Michael E Sneed
EVP, Global Corp Aff & CCO
|
Sell
For Tax Liability
|
-4.30% | 2,676 | $165.55 | $443,012 | |
|
02/12/21
Filed: *02/17/21
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Buy
Option Exercised
|
+9.74% | 10,813 | N/A | $0 | |
|
02/12/21
Filed: *02/17/21
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Buy
Option Exercised
|
+1.82% | 2,060 | N/A | $0 | |
|
02/12/21
Filed: *02/17/21
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
For Tax Liability
|
-0.68% | 761 | $165.55 | $125,984 | |
|
02/12/21
Filed: *02/17/21
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
For Tax Liability
|
-4.60% | 4,935 | $165.55 | $816,989 | |
|
02/12/21
Filed: *02/17/21
|
Joaquin Duato
Vice Chair, Exec Committee
|
Buy
Option Exercised
|
+13.58% | 27,738 | N/A | $0 | |
|
02/12/21
Filed: *02/17/21
|
Joaquin Duato
Vice Chair, Exec Committee
|
Buy
Option Exercised
|
+2.52% | 5,283 | N/A | $0 | |
|
02/12/21
Filed: *02/17/21
|
Joaquin Duato
Vice Chair, Exec Committee
|
Sell
For Tax Liability
|
-0.72% | 1,507 | $165.55 | $249,484 | |
|
02/12/21
Filed: *02/17/21
|
Joaquin Duato
Vice Chair, Exec Committee
|
Sell
For Tax Liability
|
-6.09% | 11,931 | $165.55 | $1,975,177 | |
|
02/08/21
Filed: *02/10/21
|
Alex Gorsky
Chairman, CEO
|
Buy
Will Transfer
|
+0.61% | 2,750 | N/A | $0 | |
|
02/08/21
Filed: *02/10/21
|
Alex Gorsky
Chairman, CEO
|
Sell
Bona Fide Gift
|
-1.56% | 6,990 | N/A | $0 | |
|
02/08/21
Filed: *02/10/21
|
Alex Gorsky
Chairman, CEO
|
Sell
Bona Fide Gift
|
-3.23% | 13,960 | N/A | $0 | |
|
12/09/20
Filed: *12/10/20
|
Michael E Sneed
EVP, Global Corp Aff & COO
|
Buy
Option Exercised
|
+49.36% | 54,662 | $62.20 | $3,399,976 | |
|
12/09/20
Filed: *12/10/20
|
Michael E Sneed
EVP, Global Corp Aff & COO
|
Sell
Open Market Sell
|
-97.47% | 54,662 | $152.93 | $8,359,460 | |
|
09/02/20
Filed: *09/04/20
|
Kathryn E Wengel
EVP, Chief GSC Officer
|
Buy
Option Exercised
|
+12.36% | 8,238 | $62.20 | $512,404 | |
|
09/02/20
Filed: *09/04/20
|
Kathryn E Wengel
EVP, Chief GSC Officer
|
Buy
Option Exercised
|
+10.57% | 7,877 | $65.37 | $514,919 | |
|
09/02/20
Filed: *09/04/20
|
Kathryn E Wengel
EVP, Chief GSC Officer
|
Sell
Open Market Sell
|
-11.82% | 7,877 | $153.51 | $1,209,183 | |
|
09/02/20
Filed: *09/04/20
|
Kathryn E Wengel
EVP, Chief GSC Officer
|
Sell
Open Market Sell
|
-14.10% | 8,238 | $153.53 | $1,264,755 | |
|
07/28/20
Filed: 07/28/20
|
Ashley Mcevoy
EVP, WW Chair, Medical Devices
|
Sell
Open Market Sell
|
-133.75% | 29,000 | $147.47 | $4,276,630 | |
|
03/13/20
Filed: 03/17/20
|
William D Perez
|
Buy
Open Market Buy
|
+3.12% | 500 | $127.69 | $63,843 | - |
|
02/21/20
Filed: *02/25/20
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Buy
Option Exercised
|
+25.62% | 19,224 | $90.44 | $1,738,619 | |
|
02/21/20
Filed: *02/25/20
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
Open Market Sell
|
-109.52% | 39,224 | $147.96 | $5,803,583 | |
|
02/13/20
Filed: *02/18/20
|
Kathryn E Wengel
EVP, Chief GSC Officer
|
Buy
Option Exercised
|
+14.18% | 8,217 | N/A | $0 | |
|
02/13/20
Filed: *02/18/20
|
Kathryn E Wengel
EVP, Chief GSC Officer
|
Buy
Option Exercised
|
+11.59% | 7,592 | N/A | $0 | |
|
02/13/20
Filed: *02/18/20
|
Kathryn E Wengel
EVP, Chief GSC Officer
|
Sell
For Tax Liability
|
-4.65% | 2,909 | $150.46 | $437,688 | |
|
02/13/20
Filed: *02/18/20
|
Kathryn E Wengel
EVP, Chief GSC Officer
|
Sell
For Tax Liability
|
-7.19% | 4,203 | $150.46 | $632,383 | |
|
02/13/20
Filed: *02/18/20
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+20.46% | 3,680 | N/A | $0 | |
|
02/13/20
Filed: *02/18/20
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+15.90% | 3,400 | N/A | $0 | |
|
02/13/20
Filed: *02/18/20
|
Joseph J Wolk
Exec VP, CFO
|
Sell
For Tax Liability
|
-4.80% | 979 | $150.46 | $147,300 | |
|
02/13/20
Filed: *02/18/20
|
Joseph J Wolk
Exec VP, CFO
|
Sell
For Tax Liability
|
-5.76% | 1,112 | $150.46 | $167,312 | |
|
02/13/20
Filed: *02/18/20
|
Michael H Ullmann
Exec VP, General Counsel
|
Buy
Option Exercised
|
+9.74% | 14,290 | N/A | $0 | |
|
02/13/20
Filed: *02/18/20
|
Michael H Ullmann
Exec VP, General Counsel
|
Buy
Option Exercised
|
+3.95% | 6,036 | N/A | $0 | |
|
02/13/20
Filed: *02/18/20
|
Michael H Ullmann
Exec VP, General Counsel
|
Sell
For Tax Liability
|
-1.46% | 2,194 | $150.46 | $330,109 | |
|
02/13/20
Filed: *02/18/20
|
Michael H Ullmann
Exec VP, General Counsel
|
Sell
For Tax Liability
|
-5.04% | 7,219 | $150.46 | $1,086,171 | |
|
02/13/20
Filed: *02/18/20
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Buy
Option Exercised
|
+7.73% | 8,360 | N/A | $0 | |
|
02/13/20
Filed: *02/18/20
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Buy
Option Exercised
|
+6.67% | 7,724 | N/A | $0 | |
|
02/13/20
Filed: *02/18/20
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Sell
For Tax Liability
|
-3.53% | 3,951 | $150.46 | $594,467 | |
|
02/13/20
Filed: *02/18/20
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Sell
For Tax Liability
|
-3.98% | 4,277 | $150.46 | $643,517 | |
|
02/13/20
Filed: *02/18/20
|
Paulus Stoffels
Vice Chair, Exec Committee
|
Buy
Option Exercised
|
+10.68% | 27,686 | N/A | $0 | |
|
02/13/20
Filed: *02/18/20
|
Paulus Stoffels
Vice Chair, Exec Committee
|
Buy
Option Exercised
|
+4.32% | 11,695 | N/A | $0 | |
|
02/13/20
Filed: *02/18/20
|
Paulus Stoffels
Vice Chair, Exec Committee
|
Sell
For Tax Liability
|
-1.53% | 4,079 | $150.46 | $613,726 | |
|
02/13/20
Filed: *02/18/20
|
Paulus Stoffels
Vice Chair, Exec Committee
|
Sell
For Tax Liability
|
-4.72% | 12,022 | $150.46 | $1,808,830 | |
|
02/13/20
Filed: *02/18/20
|
Michael E Sneed
EVP, Global Corp Aff & COO
|
Buy
Option Exercised
|
+11.08% | 6,152 | N/A | $0 | |
|
02/13/20
Filed: *02/18/20
|
Michael E Sneed
EVP, Global Corp Aff & COO
|
Buy
Option Exercised
|
+9.28% | 5,684 | N/A | $0 | |
|
02/13/20
Filed: *02/18/20
|
Michael E Sneed
EVP, Global Corp Aff & COO
|
Sell
For Tax Liability
|
-4.20% | 2,468 | $150.46 | $371,335 | |
|
02/13/20
Filed: *02/18/20
|
Michael E Sneed
EVP, Global Corp Aff & COO
|
Sell
For Tax Liability
|
-4.76% | 2,672 | $150.46 | $402,029 | |
|
02/13/20
Filed: *02/18/20
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Buy
Option Exercised
|
+3.46% | 1,919 | N/A | $0 | |
|
02/13/20
Filed: *02/18/20
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Buy
Option Exercised
|
+3.10% | 1,773 | N/A | $0 | |
|
02/13/20
Filed: *02/18/20
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
For Tax Liability
|
-1.23% | 694 | $150.46 | $104,419 | |
|
02/13/20
Filed: *02/18/20
|
Thibaut Mongon
Exec VP, WW Chair, Consumer
|
Sell
For Tax Liability
|
-1.34% | 750 | $150.46 | $112,845 | |
|
02/13/20
Filed: *02/18/20
|
Ashley Mcevoy
EVP, WW Chair, Medical Devices
|
Buy
Option Exercised
|
+14.32% | 7,145 | N/A | $0 | |
|
02/13/20
Filed: *02/18/20
|
Ashley Mcevoy
EVP, WW Chair, Medical Devices
|
Buy
Option Exercised
|
+11.69% | 6,602 | N/A | $0 | |
|
02/13/20
Filed: *02/18/20
|
Ashley Mcevoy
EVP, WW Chair, Medical Devices
|
Sell
For Tax Liability
|
-5.22% | 2,801 | $150.46 | $421,438 | |
|
02/13/20
Filed: *02/18/20
|
Ashley Mcevoy
EVP, WW Chair, Medical Devices
|
Sell
For Tax Liability
|
-5.98% | 3,031 | $150.46 | $456,044 | |
|
02/13/20
Filed: *02/18/20
|
Alex Gorsky
Chairman, CEO
|
Buy
Option Exercised
|
+16.19% | 75,237 | N/A | $0 | |
|
02/13/20
Filed: *02/18/20
|
Alex Gorsky
Chairman, CEO
|
Buy
Option Exercised
|
+6.40% | 31,779 | N/A | $0 | |
|
02/13/20
Filed: *02/18/20
|
Alex Gorsky
Chairman, CEO
|
Sell
For Tax Liability
|
-2.65% | 12,803 | $150.46 | $1,926,339 | |
|
02/13/20
Filed: *02/18/20
|
Alex Gorsky
Chairman, CEO
|
Sell
For Tax Liability
|
-7.24% | 32,668 | $150.46 | $4,915,227 | |
|
02/13/20
Filed: *02/18/20
|
Joaquin Duato
Vice Chair, Exec Committee
|
Buy
Option Exercised
|
+38.14% | 70,733 | N/A | $0 | |
|
02/13/20
Filed: *02/18/20
|
Joaquin Duato
Vice Chair, Exec Committee
|
Buy
Option Exercised
|
+11.70% | 24,561 | N/A | $0 | |
|
02/13/20
Filed: *02/18/20
|
Joaquin Duato
Vice Chair, Exec Committee
|
Buy
Option Exercised
|
+4.71% | 10,374 | N/A | $0 | |
|
02/13/20
Filed: *02/18/20
|
Joaquin Duato
Vice Chair, Exec Committee
|
Sell
For Tax Liability
|
-1.62% | 3,513 | $150.46 | $528,566 | |
|
02/13/20
Filed: *02/18/20
|
Joaquin Duato
Vice Chair, Exec Committee
|
Sell
For Tax Liability
|
-5.17% | 10,670 | $150.46 | $1,605,408 | |
|
02/13/20
Filed: *02/18/20
|
Joaquin Duato
Vice Chair, Exec Committee
|
Sell
For Tax Liability
|
-16.84% | 29,721 | $150.46 | $4,471,822 | |
|
02/13/20
Filed: *02/18/20
|
Robert J Decker
Controller, CAO
|
Buy
Option Exercised
|
+5.89% | 779 | N/A | $0 | |
|
02/13/20
Filed: *02/18/20
|
Robert J Decker
Controller, CAO
|
Buy
Option Exercised
|
+5.16% | 720 | N/A | $0 | |
|
02/13/20
Filed: *02/18/20
|
Robert J Decker
Controller, CAO
|
Sell
For Tax Liability
|
-1.97% | 270 | $150.46 | $40,624 | |
|
02/13/20
Filed: *02/18/20
|
Robert J Decker
Controller, CAO
|
Sell
For Tax Liability
|
-2.13% | 285 | $150.46 | $42,881 | |
|
02/13/20
Filed: *02/18/20
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Buy
Option Exercised
|
+15.03% | 15,629 | N/A | $0 | |
|
02/13/20
Filed: *02/18/20
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Buy
Option Exercised
|
+5.97% | 6,602 | N/A | $0 | |
|
02/13/20
Filed: *02/18/20
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
For Tax Liability
|
-2.22% | 2,404 | $150.46 | $361,706 | |
|
02/13/20
Filed: *02/18/20
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
For Tax Liability
|
-7.98% | 7,989 | $150.46 | $1,202,025 | |
|
09/11/19
Filed: 02/13/20
|
William D Perez
|
Sell
Bona Fide Gift
|
-17.33% | 2,692 | N/A | $0 | |
|
02/10/20
Filed: *02/12/20
|
Michael H Ullmann
Exec VP, General Counsel
|
Sell
Bona Fide Gift
|
-0.55% | 736 | N/A | $0 | |
|
02/10/20
Filed: *02/12/20
|
Michael H Ullmann
Exec VP, General Counsel
|
Sell
Bona Fide Gift
|
-0.27% | 353 | N/A | $0 | |
|
02/03/20
Filed: *02/04/20
|
Ashley Mcevoy
EVP, WW Chair, Medical Devices
|
Buy
Option Exercised
|
+66.46% | 38,650 | N/A | $0 | |
|
02/03/20
Filed: *02/04/20
|
Ashley Mcevoy
EVP, WW Chair, Medical Devices
|
Sell
For Tax Liability
|
-36.04% | 15,405 | $149.32 | $2,300,275 | |
|
02/03/20
Filed: *02/04/20
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Buy
Option Exercised
|
+39.13% | 48,312 | N/A | $0 | |
|
02/03/20
Filed: *02/04/20
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Sell
For Tax Liability
|
-23.79% | 23,721 | $149.32 | $3,542,020 | |
|
01/30/20
Filed: *02/03/20
|
Michael E Sneed
EVP, Global Corp Aff & COO
|
Buy
Option Exercised
|
+54.07% | 58,128 | $62.62 | $3,639,975 | |
|
01/30/20
Filed: *02/03/20
|
Michael E Sneed
EVP, Global Corp Aff & COO
|
Sell
Open Market Sell
|
-117.71% | 58,128 | $149.39 | $8,683,568 | |
|
12/31/19
Filed: *01/16/20
|
Anne M Mulcahy
|
Buy
Will Transfer
|
+3.69% | 270 | N/A | $0 | - |
|
12/31/19
Filed: *01/16/20
|
Anne M Mulcahy
|
Buy
Will Transfer
|
+4.89% | 358 | N/A | $0 | - |
|
12/12/19
Filed: *12/16/19
|
Kathryn E Wengel
EVP, Chief GSC Officer
|
Buy
Option Exercised
|
+3.90% | 2,017 | $62.62 | $126,305 | |
|
12/12/19
Filed: *12/16/19
|
Kathryn E Wengel
EVP, Chief GSC Officer
|
Sell
Open Market Sell
|
-4.06% | 2,017 | $141.07 | $284,538 | |
|
12/13/19
Filed: 12/16/19
|
Hubert Joly
|
Buy
Open Market Buy
|
+100.00% | 5,000 | $141.28 | $706,399 | - |
|
06/11/19
Filed: 06/11/19
|
Marillyn A Hewson
|
Buy
Open Market Buy
|
+100.00% | 3,000 | $139.68 | $419,040 | - |
|
02/08/19
Filed: *02/12/19
|
Ronald A Kapusta
Controller, CAO
|
Buy
Option Exercised
|
+15.40% | 2,484 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Ronald A Kapusta
Controller, CAO
|
Sell
For Tax Liability
|
-4.76% | 733 | $132.00 | $96,756 | |
|
02/08/19
Filed: *02/12/19
|
Ronald A Kapusta
Controller, CAO
|
Buy
Option Exercised
|
+15.57% | 2,839 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Ronald A Kapusta
Controller, CAO
|
Buy
Grant, Award
|
+2.49% | 466 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Ronald A Kapusta
Controller, CAO
|
Sell
For Tax Liability
|
-5.29% | 940 | $131.94 | $124,024 | |
|
02/08/19
Filed: *02/12/19
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+20.75% | 2,540 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Joseph J Wolk
Exec VP, CFO
|
Sell
For Tax Liability
|
-6.41% | 737 | $132.00 | $97,284 | |
|
02/08/19
Filed: *02/12/19
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+20.15% | 2,903 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Grant, Award
|
+3.20% | 476 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Joseph J Wolk
Exec VP, CFO
|
Sell
For Tax Liability
|
-6.90% | 961 | $131.94 | $126,794 | |
|
02/08/19
Filed: *02/12/19
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Buy
Option Exercised
|
+6.05% | 5,044 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
For Tax Liability
|
-2.50% | 2,033 | $132.00 | $268,356 | |
|
02/08/19
Filed: *02/12/19
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Buy
Option Exercised
|
+13.42% | 12,609 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Buy
Grant, Award
|
+2.15% | 2,068 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
For Tax Liability
|
-8.70% | 7,687 | $131.94 | $1,014,223 | |
|
02/08/19
Filed: *02/12/19
|
Kathryn E Wengel
EVP, Chief GSC Officer
|
Buy
Option Exercised
|
+14.63% | 5,882 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Kathryn E Wengel
EVP, Chief GSC Officer
|
Sell
For Tax Liability
|
-6.27% | 2,373 | $132.00 | $313,236 | |
|
02/08/19
Filed: *02/12/19
|
Kathryn E Wengel
EVP, Chief GSC Officer
|
Buy
Option Exercised
|
+15.09% | 6,722 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Kathryn E Wengel
EVP, Chief GSC Officer
|
Buy
Grant, Award
|
+2.41% | 1,102 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Kathryn E Wengel
EVP, Chief GSC Officer
|
Sell
For Tax Liability
|
-9.73% | 4,047 | $131.94 | $533,961 | |
|
02/08/19
Filed: *02/12/19
|
Michael H Ullmann
Exec VP, General Counsel
|
Sell
Bona Fide Gift
|
-0.31% | 380 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Michael H Ullmann
Exec VP, General Counsel
|
Sell
Bona Fide Gift
|
-0.31% | 385 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Michael H Ullmann
Exec VP, General Counsel
|
Buy
Option Exercised
|
+4.14% | 5,309 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Michael H Ullmann
Exec VP, General Counsel
|
Sell
For Tax Liability
|
-1.69% | 2,133 | $132.00 | $281,556 | |
|
02/08/19
Filed: *02/12/19
|
Michael H Ullmann
Exec VP, General Counsel
|
Buy
Option Exercised
|
+9.52% | 13,273 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Michael H Ullmann
Exec VP, General Counsel
|
Buy
Grant, Award
|
+1.54% | 2,177 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Michael H Ullmann
Exec VP, General Counsel
|
Sell
For Tax Liability
|
-6.11% | 8,151 | $131.94 | $1,075,443 | |
|
02/08/19
Filed: *02/12/19
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Buy
Option Exercised
|
+11.81% | 8,529 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Sell
For Tax Liability
|
-5.19% | 3,565 | $132.00 | $470,580 | |
|
02/08/19
Filed: *02/12/19
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Buy
Option Exercised
|
+12.44% | 9,748 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Buy
Grant, Award
|
+2.00% | 1,599 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Sell
For Tax Liability
|
-8.46% | 6,236 | $131.94 | $822,778 | |
|
02/08/19
Filed: *02/12/19
|
Paulus Stoffels
Vice Chair, Exec Committee
|
Buy
Option Exercised
|
+5.84% | 12,571 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Paulus Stoffels
Vice Chair, Exec Committee
|
Sell
For Tax Liability
|
-2.05% | 4,320 | $132.00 | $570,240 | |
|
02/08/19
Filed: *02/12/19
|
Paulus Stoffels
Vice Chair, Exec Committee
|
Buy
Option Exercised
|
+12.97% | 31,428 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Paulus Stoffels
Vice Chair, Exec Committee
|
Buy
Grant, Award
|
+2.08% | 5,154 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Paulus Stoffels
Vice Chair, Exec Committee
|
Sell
For Tax Liability
|
-6.86% | 15,884 | $131.94 | $2,095,735 | |
|
02/08/19
Filed: *02/12/19
|
Michael E Sneed
EVP, Global Corp Aff & COO
|
Buy
Option Exercised
|
+13.77% | 6,365 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Michael E Sneed
EVP, Global Corp Aff & COO
|
Sell
For Tax Liability
|
-4.11% | 1,827 | $132.00 | $241,164 | |
|
02/08/19
Filed: *02/12/19
|
Michael E Sneed
EVP, Global Corp Aff & COO
|
Buy
Option Exercised
|
+14.08% | 7,275 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Michael E Sneed
EVP, Global Corp Aff & COO
|
Buy
Grant, Award
|
+2.26% | 1,193 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Michael E Sneed
EVP, Global Corp Aff & COO
|
Sell
For Tax Liability
|
-7.08% | 3,497 | $131.94 | $461,394 | |
|
02/08/19
Filed: *02/12/19
|
Jorge S. Mesquita
Exec VP, WW Chair, Consumer
|
Buy
Option Exercised
|
+30.60% | 6,787 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Jorge S. Mesquita
Exec VP, WW Chair, Consumer
|
Sell
For Tax Liability
|
-15.70% | 3,009 | $132.00 | $397,188 | |
|
02/08/19
Filed: *02/12/19
|
Jorge S. Mesquita
Exec VP, WW Chair, Consumer
|
Buy
Option Exercised
|
+46.95% | 16,968 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Jorge S. Mesquita
Exec VP, WW Chair, Consumer
|
Buy
Grant, Award
|
+7.15% | 2,783 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Jorge S. Mesquita
Exec VP, WW Chair, Consumer
|
Sell
For Tax Liability
|
-42.34% | 11,577 | $131.94 | $1,527,469 | |
|
02/08/19
Filed: *02/12/19
|
Ashley Mcevoy
EVP, WW Chair, Medical Devices
|
Buy
Option Exercised
|
+41.01% | 6,599 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Ashley Mcevoy
EVP, WW Chair, Medical Devices
|
Sell
For Tax Liability
|
-12.78% | 1,824 | $132.00 | $240,768 | |
|
02/08/19
Filed: *02/12/19
|
Ashley Mcevoy
EVP, WW Chair, Medical Devices
|
Buy
Option Exercised
|
+34.58% | 7,541 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Ashley Mcevoy
EVP, WW Chair, Medical Devices
|
Buy
Grant, Award
|
+5.37% | 1,237 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Ashley Mcevoy
EVP, WW Chair, Medical Devices
|
Sell
For Tax Liability
|
-18.38% | 3,578 | $131.94 | $472,081 | |
|
02/08/19
Filed: *02/12/19
|
Alex Gorsky
Chairman, CEO
|
Sell
Bona Fide Gift
|
-2.07% | 6,837 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Alex Gorsky
Chairman, CEO
|
Sell
Bona Fide Gift
|
-2.12% | 6,837 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Alex Gorsky
Chairman, CEO
|
Buy
Option Exercised
|
+8.39% | 29,579 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Alex Gorsky
Chairman, CEO
|
Sell
For Tax Liability
|
-3.44% | 11,708 | $132.00 | $1,545,456 | |
|
02/08/19
Filed: *02/12/19
|
Alex Gorsky
Chairman, CEO
|
Buy
Option Exercised
|
+17.83% | 73,947 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Alex Gorsky
Chairman, CEO
|
Buy
Grant, Award
|
+2.84% | 12,127 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Alex Gorsky
Chairman, CEO
|
Sell
For Tax Liability
|
-9.60% | 37,374 | $131.94 | $4,931,126 | |
|
02/08/19
Filed: *02/12/19
|
Joaquin Duato
Vice Chair, Exec Committee
|
Buy
Option Exercised
|
+8.82% | 9,049 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Joaquin Duato
Vice Chair, Exec Committee
|
Sell
For Tax Liability
|
-2.80% | 2,798 | $132.00 | $369,336 | |
|
02/08/19
Filed: *02/12/19
|
Joaquin Duato
Vice Chair, Exec Committee
|
Buy
Option Exercised
|
+18.48% | 22,624 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Joaquin Duato
Vice Chair, Exec Committee
|
Buy
Grant, Award
|
+2.94% | 3,710 | N/A | $0 | |
|
02/08/19
Filed: *02/12/19
|
Joaquin Duato
Vice Chair, Exec Committee
|
Sell
For Tax Liability
|
-9.97% | 11,435 | $131.94 | $1,508,734 | |
|
12/14/18
Filed: 12/17/18
|
Anne M Mulcahy
|
Buy
Open Market Buy
|
+11.44% | 748 | $133.76 | $100,050 | - |
|
12/14/18
Filed: 12/17/18
|
William D Perez
|
Buy
Open Market Buy
|
+10.96% | 1,000 | $133.91 | $133,910 | - |
|
12/14/18
Filed: 12/17/18
|
Charles Prince
|
Buy
Open Market Buy
|
+7.01% | 2,000 | $134.37 | $268,731 | - |
|
12/13/18
Filed: 12/14/18
|
Ronald A Kapusta
Controller, CAO
|
Sell
Open Market Sell
|
-26.71% | 3,643 | $147.31 | $536,638 | |
|
12/03/18
Filed: *12/06/18
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Buy
Option Exercised
|
+49.64% | 77,213 | $90.44 | $6,983,144 | |
|
12/03/18
Filed: *12/06/18
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Buy
Option Exercised
|
+23.55% | 47,919 | $100.06 | $4,794,775 | |
|
12/03/18
Filed: *12/06/18
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-159.76% | 125,132 | $146.31 | $18,308,689 | |
|
12/03/18
Filed: *12/06/18
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Buy
Option Exercised
|
+25.75% | 27,160 | $100.06 | $2,717,630 | |
|
12/03/18
Filed: *12/06/18
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Buy
Option Exercised
|
+12.01% | 14,403 | $90.44 | $1,302,607 | |
|
12/03/18
Filed: *12/06/18
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-53.06% | 41,563 | $146.68 | $6,096,552 | |
|
11/23/18
Filed: *11/27/18
|
Michael E Sneed
EVP, Global Corp Aff & COO
|
Buy
Option Exercised
|
+43.69% | 30,943 | $58.33 | $1,804,905 | |
|
11/23/18
Filed: *11/27/18
|
Michael E Sneed
EVP, Global Corp Aff & COO
|
Sell
Open Market Sell
|
-77.60% | 30,943 | $142.46 | $4,407,985 | |
|
11/16/18
Filed: *11/16/18
|
Alex Gorsky
Chairman, CEO
|
Buy
Option Exercised
|
+30.07% | 144,695 | $62.20 | $9,000,029 | |
|
11/16/18
Filed: *11/16/18
|
Alex Gorsky
Chairman, CEO
|
Buy
Option Exercised
|
+19.93% | 119,770 | $62.62 | $7,499,997 | |
|
11/16/18
Filed: *11/16/18
|
Alex Gorsky
Chairman, CEO
|
Sell
Open Market Sell
|
-78.58% | 264,465 | $145.96 | $38,600,968 | |
|
11/08/18
Filed: 11/09/18
|
Ronald A Kapusta
Controller, CAO
|
Sell
Open Market Sell
|
-48.84% | 8,441 | $145.15 | $1,225,200 | |
|
11/07/18
Filed: *11/09/18
|
Joaquin Duato
Vice Chair, Exec Committee
|
Buy
Option Exercised
|
+17.10% | 19,293 | $62.20 | $1,200,025 | |
|
11/07/18
Filed: *11/09/18
|
Joaquin Duato
Vice Chair, Exec Committee
|
Buy
Option Exercised
|
+12.13% | 15,577 | $65.37 | $1,018,268 | |
|
11/07/18
Filed: *11/09/18
|
Joaquin Duato
Vice Chair, Exec Committee
|
Buy
Option Exercised
|
+3.84% | 5,130 | $58.33 | $299,233 | |
|
11/07/18
Filed: *11/09/18
|
Joaquin Duato
Vice Chair, Exec Committee
|
Sell
Open Market Sell
|
-42.76% | 40,000 | $144.36 | $5,774,480 | |
|
08/27/18
Filed: 09/17/18
|
Ashley Mcevoy
EVP, WW Chair, Medical Devices
|
Sell
Discretionary Transaction
|
-6.41% | 142 | $134.92 | $19,159 | |
|
09/07/18
Filed: 09/11/18
|
Ronald A Kapusta
Controller, CAO
|
Sell
Open Market Sell
|
-30.71% | 7,899 | $137.18 | $1,083,607 | |
|
08/27/18
Filed: *08/28/18
|
Michael E Sneed
EVP, Global Corp Aff & COO
|
Buy
Option Exercised
|
+49.05% | 29,000 | $58.33 | $1,691,570 | |
|
08/27/18
Filed: *08/28/18
|
Michael E Sneed
EVP, Global Corp Aff & COO
|
Sell
Open Market Sell
|
-96.27% | 29,000 | $134.80 | $3,909,084 | |
|
02/15/18
Filed: *02/20/18
|
Paulus Stoffels
Exec VP, Chief Scientific Off
|
Buy
Option Exercised
|
+43.40% | 155,342 | $90.44 | $14,049,130 | |
|
02/15/18
Filed: *02/20/18
|
Paulus Stoffels
Exec VP, Chief Scientific Off
|
Sell
Open Market Sell
|
-76.69% | 155,342 | $129.86 | $20,172,401 | |
|
02/12/18
Filed: *02/14/18
|
Ronald A Kapusta
Controller, CAO
|
Buy
Option Exercised
|
+5.35% | 1,801 | N/A | $0 | |
|
02/12/18
Filed: *02/14/18
|
Ronald A Kapusta
Controller, CAO
|
Buy
Grant, Award
|
+1.89% | 649 | N/A | $0 | |
|
02/12/18
Filed: *02/14/18
|
Ronald A Kapusta
Controller, CAO
|
Sell
For Tax Liability
|
-2.07% | 697 | $129.51 | $90,268 | |
|
02/12/18
Filed: *02/14/18
|
Joaquin Duato
Exec VP, WW Chair, Pharma
|
Buy
Option Exercised
|
+24.73% | 24,530 | N/A | $0 | |
|
02/12/18
Filed: *02/14/18
|
Joaquin Duato
Exec VP, WW Chair, Pharma
|
Buy
Grant, Award
|
+8.17% | 8,831 | N/A | $0 | |
|
02/12/18
Filed: *02/14/18
|
Joaquin Duato
Exec VP, WW Chair, Pharma
|
Sell
For Tax Liability
|
-15.48% | 14,486 | $129.51 | $1,876,082 | |
|
02/12/18
Filed: *02/14/18
|
Paulus Stoffels
Exec VP, Chief Scientific Off
|
Buy
Option Exercised
|
+15.76% | 33,130 | N/A | $0 | |
|
02/12/18
Filed: *02/14/18
|
Paulus Stoffels
Exec VP, Chief Scientific Off
|
Buy
Grant, Award
|
+5.37% | 11,927 | N/A | $0 | |
|
02/12/18
Filed: *02/14/18
|
Paulus Stoffels
Exec VP, Chief Scientific Off
|
Sell
For Tax Liability
|
-9.66% | 19,564 | $129.51 | $2,533,734 | |
|
02/12/18
Filed: *02/14/18
|
Dominic J Caruso
Exec VP, Finance; CFO
|
Buy
Option Exercised
|
+14.91% | 26,504 | N/A | $0 | |
|
02/12/18
Filed: *02/14/18
|
Dominic J Caruso
Exec VP, Finance; CFO
|
Buy
Grant, Award
|
+5.09% | 9,542 | N/A | $0 | |
|
02/12/18
Filed: *02/14/18
|
Dominic J Caruso
Exec VP, Finance; CFO
|
Sell
For Tax Liability
|
-9.12% | 15,652 | $129.51 | $2,027,091 | |
|
02/12/18
Filed: *02/14/18
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Buy
Option Exercised
|
+17.65% | 14,574 | N/A | $0 | |
|
02/12/18
Filed: *02/14/18
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Buy
Grant, Award
|
+5.98% | 5,247 | N/A | $0 | |
|
02/12/18
Filed: *02/14/18
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
For Tax Liability
|
-12.09% | 9,471 | $129.51 | $1,226,589 | |
|
02/12/18
Filed: *02/14/18
|
Michael H Ullmann
Exec VP, General Counsel
|
Buy
Option Exercised
|
+11.62% | 14,882 | N/A | $0 | |
|
02/12/18
Filed: *02/14/18
|
Michael H Ullmann
Exec VP, General Counsel
|
Buy
Grant, Award
|
+4.02% | 5,358 | N/A | $0 | |
|
02/12/18
Filed: *02/14/18
|
Michael H Ullmann
Exec VP, General Counsel
|
Sell
For Tax Liability
|
-7.83% | 9,695 | $129.51 | $1,255,599 | |
|
02/12/18
Filed: *02/14/18
|
Sandra E Peterson
Exec VP, Group WW Chairman
|
Buy
Option Exercised
|
+30.48% | 28,612 | N/A | $0 | |
|
02/12/18
Filed: *02/14/18
|
Sandra E Peterson
Exec VP, Group WW Chairman
|
Buy
Grant, Award
|
+9.89% | 10,301 | N/A | $0 | |
|
02/12/18
Filed: *02/14/18
|
Sandra E Peterson
Exec VP, Group WW Chairman
|
Sell
For Tax Liability
|
-24.98% | 20,819 | $129.51 | $2,696,269 | |
|
02/12/18
Filed: *02/14/18
|
Alex Gorsky
Chairman, CEO
|
Buy
Option Exercised
|
+23.31% | 82,913 | N/A | $0 | |
|
02/12/18
Filed: *02/14/18
|
Alex Gorsky
Chairman, CEO
|
Buy
Grant, Award
|
+7.74% | 29,849 | N/A | $0 | |
|
02/12/18
Filed: *02/14/18
|
Alex Gorsky
Chairman, CEO
|
Sell
For Tax Liability
|
-14.55% | 48,962 | $129.51 | $6,341,069 | |
|
02/09/18
Filed: *02/13/18
|
Ronald A Kapusta
Controller, CAO
|
Buy
Option Exercised
|
+8.27% | 2,702 | N/A | $0 | |
|
02/09/18
Filed: *02/13/18
|
Ronald A Kapusta
Controller, CAO
|
Sell
For Tax Liability
|
-2.49% | 795 | $128.18 | $101,903 | |
|
02/09/18
Filed: *02/13/18
|
Michael H Ullmann
Exec VP, General Counsel
|
Sell
Bona Fide Gift
|
-0.19% | 208 | N/A | $0 | |
|
02/09/18
Filed: *02/13/18
|
Michael H Ullmann
Exec VP, General Counsel
|
Sell
Bona Fide Gift
|
-0.37% | 409 | N/A | $0 | |
|
02/09/18
Filed: *02/13/18
|
Michael H Ullmann
Exec VP, General Counsel
|
Sell
Bona Fide Gift
|
-0.16% | 179 | N/A | $0 | |
|
02/09/18
Filed: *02/13/18
|
Michael H Ullmann
Exec VP, General Counsel
|
Buy
Option Exercised
|
+5.16% | 5,953 | N/A | $0 | |
|
02/09/18
Filed: *02/13/18
|
Michael H Ullmann
Exec VP, General Counsel
|
Sell
For Tax Liability
|
-1.81% | 2,052 | $128.18 | $263,025 | |
|
02/09/18
Filed: *02/13/18
|
Paulus Stoffels
Exec VP, Chief Scientific Off
|
Buy
Option Exercised
|
+7.30% | 13,252 | N/A | $0 | |
|
02/09/18
Filed: *02/13/18
|
Paulus Stoffels
Exec VP, Chief Scientific Off
|
Sell
For Tax Liability
|
-2.59% | 4,584 | $128.18 | $587,577 | |
|
02/09/18
Filed: *02/13/18
|
Sandra E Peterson
Exec VP, Group WW Chairman
|
Buy
Option Exercised
|
+16.30% | 11,445 | N/A | $0 | |
|
02/09/18
Filed: *02/13/18
|
Sandra E Peterson
Exec VP, Group WW Chairman
|
Sell
For Tax Liability
|
-7.59% | 4,950 | $128.18 | $634,491 | |
|
02/09/18
Filed: *02/13/18
|
Alex Gorsky
Chairman, CEO
|
Sell
Bona Fide Gift
|
-2.83% | 7,153 | N/A | $0 | |
|
02/09/18
Filed: *02/13/18
|
Alex Gorsky
Chairman, CEO
|
Buy
Option Exercised
|
+11.60% | 33,165 | N/A | $0 | |
|
02/09/18
Filed: *02/13/18
|
Alex Gorsky
Chairman, CEO
|
Sell
For Tax Liability
|
-4.85% | 13,231 | $128.18 | $1,695,950 | |
|
02/09/18
Filed: *02/13/18
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Buy
Option Exercised
|
+8.33% | 5,830 | N/A | $0 | |
|
02/09/18
Filed: *02/13/18
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
For Tax Liability
|
-2.96% | 2,015 | $128.18 | $258,283 | |
|
02/09/18
Filed: *02/13/18
|
Joaquin Duato
Exec VP, WW Chair, Pharma
|
Buy
Option Exercised
|
+12.52% | 9,812 | N/A | $0 | |
|
02/09/18
Filed: *02/13/18
|
Joaquin Duato
Exec VP, WW Chair, Pharma
|
Sell
For Tax Liability
|
-4.91% | 3,668 | $128.18 | $470,164 | |
|
02/09/18
Filed: *02/13/18
|
Dominic J Caruso
Exec VP, Finance; CFO
|
Buy
Option Exercised
|
+6.85% | 10,601 | N/A | $0 | |
|
02/09/18
Filed: *02/13/18
|
Dominic J Caruso
Exec VP, Finance; CFO
|
Sell
For Tax Liability
|
-2.27% | 3,438 | $128.18 | $440,683 | |
|
02/02/18
Filed: *02/06/18
|
Jorge S. Mesquita
Exec VP, WW Chair, Consumer
|
Buy
Option Exercised
|
+100.00% | 32,688 | N/A | $0 | |
|
02/02/18
Filed: *02/06/18
|
Jorge S. Mesquita
Exec VP, WW Chair, Consumer
|
Sell
For Tax Liability
|
-112.37% | 17,296 | $138.88 | $2,402,068 | |
|
12/12/17
Filed: 12/14/17
|
William D Perez
|
Sell
Bona Fide Gift
|
-26.37% | 2,400 | N/A | $0 | |
|
10/31/17
Filed: *11/02/17
|
Paulus Stoffels
Exec VP, Chief Scientific Off
|
Buy
Option Exercised
|
+37.16% | 75,492 | N/A | $0 | |
|
10/31/17
Filed: *11/02/17
|
Paulus Stoffels
Exec VP, Chief Scientific Off
|
Sell
For Tax Liability
|
-20.63% | 34,742 | $139.54 | $4,847,899 | |
|
07/24/17
Filed: *07/26/17
|
Paulus Stoffels
Exec VP, Chief Scientific Off
|
Buy
Option Exercised
|
+44.58% | 102,692 | $72.54 | $7,449,278 | |
|
07/24/17
Filed: *07/26/17
|
Paulus Stoffels
Exec VP, Chief Scientific Off
|
Sell
Open Market Sell
|
-80.45% | 102,692 | $133.14 | $13,672,629 | |
|
07/20/17
Filed: *07/24/17
|
Dominic J Caruso
Exec VP, Finance; CFO
|
Buy
Option Exercised
|
+36.43% | 82,591 | $61.75 | $5,099,994 | |
|
07/20/17
Filed: *07/24/17
|
Dominic J Caruso
Exec VP, Finance; CFO
|
Sell
Open Market Sell
|
-57.31% | 82,591 | $136.72 | $11,291,478 | |
|
03/03/17
Filed: *03/07/17
|
Joaquin Duato
Exec VP, WW Chair, Pharma
|
Buy
Option Exercised
|
+29.85% | 29,158 | $58.33 | $1,700,786 | |
|
03/03/17
Filed: *03/07/17
|
Joaquin Duato
Exec VP, WW Chair, Pharma
|
Buy
Option Exercised
|
+17.58% | 20,842 | $61.75 | $1,286,994 | |
|
03/03/17
Filed: *03/07/17
|
Joaquin Duato
Exec VP, WW Chair, Pharma
|
Sell
Open Market Sell
|
-72.95% | 50,000 | $123.62 | $6,181,140 | |
|
02/28/17
Filed: *03/02/17
|
Ronald A Kapusta
Controller, CAO
|
Buy
Option Exercised
|
+32.68% | 14,543 | $72.54 | $1,054,949 | |
|
02/28/17
Filed: *03/02/17
|
Ronald A Kapusta
Controller, CAO
|
Sell
Open Market Sell
|
-48.53% | 14,543 | $122.25 | $1,777,954 | |
|
02/28/17
Filed: 03/02/17
|
Gary J Pruden
Exec VP, WW Chair, Med Devices
|
Sell
Open Market Sell
|
-37.36% | 16,299 | $122.21 | $1,991,943 | |
|
02/15/17
Filed: 02/16/17
|
Paulus Stoffels
Exec VP, Chief Scientific Off
|
Sell
Open Market Sell
|
-17.23% | 22,000 | $117.29 | $2,580,274 | |
|
02/13/17
Filed: *02/16/17
|
Joaquin Duato
Exec VP, WW Chair, Pharma
|
Buy
Option Exercised
|
+29.41% | 22,298 | N/A | $0 | |
|
02/13/17
Filed: *02/16/17
|
Joaquin Duato
Exec VP, WW Chair, Pharma
|
Buy
Grant, Award
|
+10.50% | 8,897 | N/A | $0 | |
|
02/13/17
Filed: *02/16/17
|
Joaquin Duato
Exec VP, WW Chair, Pharma
|
Sell
For Tax Liability
|
-23.60% | 16,175 | $115.67 | $1,870,962 | |
|
02/13/17
Filed: *02/16/17
|
Gary J Pruden
Exec VP, WW Chair, Med Devices
|
Buy
Option Exercised
|
+24.50% | 15,532 | N/A | $0 | |
|
02/13/17
Filed: *02/16/17
|
Gary J Pruden
Exec VP, WW Chair, Med Devices
|
Buy
Grant, Award
|
+8.90% | 6,197 | N/A | $0 | |
|
02/13/17
Filed: *02/16/17
|
Gary J Pruden
Exec VP, WW Chair, Med Devices
|
Sell
For Tax Liability
|
-16.14% | 9,673 | $115.67 | $1,118,876 | |
|
02/13/17
Filed: *02/16/17
|
Ronald A Kapusta
Controller, CAO
|
Buy
Option Exercised
|
+7.15% | 2,148 | N/A | $0 | |
|
02/13/17
Filed: *02/16/17
|
Ronald A Kapusta
Controller, CAO
|
Buy
Grant, Award
|
+2.77% | 857 | N/A | $0 | |
|
02/13/17
Filed: *02/16/17
|
Ronald A Kapusta
Controller, CAO
|
Sell
For Tax Liability
|
-3.15% | 945 | $115.67 | $109,308 | |
|
02/13/17
Filed: *02/16/17
|
Michael H Ullmann
Exec VP, General Counsel
|
Buy
Option Exercised
|
+12.71% | 14,600 | N/A | $0 | |
|
02/13/17
Filed: *02/16/17
|
Michael H Ullmann
Exec VP, General Counsel
|
Buy
Grant, Award
|
+4.83% | 5,825 | N/A | $0 | |
|
02/13/17
Filed: *02/16/17
|
Michael H Ullmann
Exec VP, General Counsel
|
Sell
For Tax Liability
|
-9.62% | 10,591 | $115.67 | $1,225,061 | |
|
02/13/17
Filed: *02/16/17
|
Paulus Stoffels
Exec VP, Chief Scientific Off
|
Buy
Option Exercised
|
+16.94% | 26,447 | N/A | $0 | |
|
02/13/17
Filed: *02/16/17
|
Paulus Stoffels
Exec VP, Chief Scientific Off
|
Buy
Grant, Award
|
+6.33% | 10,552 | N/A | $0 | |
|
02/13/17
Filed: *02/16/17
|
Paulus Stoffels
Exec VP, Chief Scientific Off
|
Sell
For Tax Liability
|
-11.38% | 17,027 | $115.67 | $1,969,513 | |
|
02/13/17
Filed: *02/16/17
|
Sandra E Peterson
Exec VP, Group WW Chairman
|
Buy
Option Exercised
|
+39.85% | 27,667 | N/A | $0 | |
|
02/13/17
Filed: *02/16/17
|
Sandra E Peterson
Exec VP, Group WW Chairman
|
Buy
Grant, Award
|
+13.72% | 11,039 | N/A | $0 | |
|
02/13/17
Filed: *02/16/17
|
Sandra E Peterson
Exec VP, Group WW Chairman
|
Sell
For Tax Liability
|
-36.96% | 21,715 | $115.67 | $2,511,774 | |
|
02/13/17
Filed: *02/16/17
|
Alex Gorsky
Chairman, CEO
|
Buy
Option Exercised
|
+30.04% | 84,299 | N/A | $0 | |
|
02/13/17
Filed: *02/16/17
|
Alex Gorsky
Chairman, CEO
|
Buy
Grant, Award
|
+10.70% | 33,635 | N/A | $0 | |
|
02/13/17
Filed: *02/16/17
|
Alex Gorsky
Chairman, CEO
|
Sell
For Tax Liability
|
-20.88% | 54,274 | $115.67 | $6,277,874 | |
|
02/13/17
Filed: *02/16/17
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Buy
Option Exercised
|
+22.64% | 15,598 | N/A | $0 | |
|
02/13/17
Filed: *02/16/17
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Buy
Grant, Award
|
+8.29% | 6,224 | N/A | $0 | |
|
02/13/17
Filed: *02/16/17
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
For Tax Liability
|
-17.08% | 10,961 | $115.67 | $1,267,859 | |
|
02/13/17
Filed: *02/15/17
|
Dominic J Caruso
Exec VP, Finance; CFO
|
Buy
Option Exercised
|
+17.88% | 26,947 | N/A | $0 | |
|
02/13/17
Filed: *02/15/17
|
Dominic J Caruso
Exec VP, Finance; CFO
|
Buy
Grant, Award
|
+6.66% | 10,752 | N/A | $0 | |
|
02/13/17
Filed: *02/15/17
|
Dominic J Caruso
Exec VP, Finance; CFO
|
Sell
For Tax Liability
|
-12.04% | 17,350 | $115.67 | $2,006,874 |
* Dates marked with an asterisk indicate one of multiple transactions reported in the same filing.